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CHAPTER I 
INTRODUCTION 
Dioctyl sodiijia sulfosuccinate (DSS) and polaxalene (ethylene 
(R) 
oxidepropylene oxide polymer, Pluronic F-68 ) are used frequently as 
anti-constipating agents. Combination of DSS and oxyphenistan has 
been shoxm to produce jaundice in several patients (132, 16U), and it 
is suspected that DSS increases the absorption of oxyphenistan and the 
latter causes the hepatotoxicity. Recently (29) it has been found 
that DSS is itself absorbed and that it msy enhance the absorption of 
oxyphenistan from the gastrointestinal tract. 
DSS has been shown to promote the absorption of a poorly 
absorbed drug, phenol red, from the colon of rats (96). In the same 
study, polaxalene was shown not to have any appreciable effect on the 
absorption of phenol red from the colon. However, in this study only 
one concentration of the sxirfactants was used. 
Since the action of surfactants on drug absorption is knoim to 
be concentration dependent and because more recent reports (98) have 
shown that phenol red, like most other drugs, is absorbed mainly from 
the small intestine, therefore a more detailed study of the effect of 
various concentrations of these s\irfactants on the absorption of 
phenol red was felt necessary. In addition, the effect of DSS on the 
peritoneal absorption was also carried out. 
1 
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The effect of DSS on the absorption of a poorly soluble drug, 
sulfisoxazole, was also studied. 
Biological Menbranes 
Membranes are structures of universal occtirrence in nature. 
The existence of plasma membranes and other biologic membranes is a 
basic foundation of modem cellular biology, and the idea that internal 
membrane systems constitute the basic cytoskeleton and circulatory 
system of the cell is firmly established. Compartments are formed by 
the membranes, which differ qualitatively and quantitatively in the 
substances that they contain; from this it must be concluded that all 
membranes possess selective permeability (57). 
At the end of the last century Overton (123) suggested that a 
s\ibmicroscopic lipid layer surrounds the cell and separates the cyto­
plasm from the extracellular space. This assumption was based in part 
on his finding that fat-soluble molecules readily penetrate into the 
cell. This dependence of the rate of penetration of a fat-soluble 
substance on its lipid solubility was later confirmed by the work of 
Collander (20). Subsequently, Gorter and Orendel (56) determined the 
surface area of erythrocytes and the area that would be occupied by 
the lipids extracted from the membrane and sho^ied that the latter area 
was twice as large as the eiythrocyte surface area. They concluded 
that erythrocyte surface is formed by a bimolecular lipid layer. 
Danielli and Davson (22) in 193U proposed a membrane model: a 
bimolecular leaflet composed of phospholipids on which protein molecxiles 
are adsorbed. They also pointed out that these protein molecTiles mar^r 
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impart structural solidity to the membrane which lipids alone could 
not achieve. The presence of a cross-linked network of polypeptide 
chains, if the adsorbed proteins were to unfold themselves on the 
surface of the cell, may perhaps account for the sieve-like properties 
of cell meinbranes. The concept of "pores" in the membranes was first 
postulated by Collander and Burland (21), and the effective diameter 
of these pores has been measured indirectly in the red blood cells 
(160) and in the intestinal epithelium (U6), and found to be approx­
imately l;-8 Angstroms. 
Since water-soluble ions, amino acids and sugars are adsorbed, 
the concept of "carriers" was postulated. Wilbrandt and Rosenberg (178) 
postulated that the carrier first combines with the substrate molecule 
and takes it across the membrane in some complex form which is lipo­
philic in nature; this complex then dissociates at the intracellular 
interface of the membrane and releases the substrate. 
From studies of electron micrographs of certain membranes, 
Robertson (139) modified the model of Danielli and Davson in three 
ways: (a) the number of lipid layers was limited to two, (b) instead 
of being globular, the proteins were assumed to be spread on the lipid 
layer, and (c) the membrane was assumed to have an assymetric structure. 
Benson (10) proposed a model in which the protein is largely 
globular and in the interior of the membrane to maximize hydrophobic 
interactions. The lipid molecules, however, are not arranged in a 
bilayer- Their fatty acid chains are individually intercalated into 
the folds of the protein chain, with the polar heads of the lipids at 
the exterior surfaces of the membrane in contact with the water. This 
u 
structure generated a more or less uniform complex of lipoproteins so 
it is proposed that such complexes exist as morphological subunits 
held together by hydrophobic interactions in the plane of the membrane. 
According to Singer (1^2), lipids and proteins of membranes 
are held together by non-covalent interactions and a steady state 
structure is assumed. Applying thermodynamic considerations we need 
to know whether the steady state structure of the membranes is the one 
with the lowest free energy. At the molecular level, the following 
general consequences of the thermodynamic considerations can be recog­
nized; (l) In order to maximize hydrophillic interactions, essentially 
all the ionic, zwitterionic, and highly polar groups such as sugar 
residues, which are attached to both the lipids and the proteins in 
the membrane, should be in contact with the bulk aqueous phase. (2) 
Models must attempt to maximize hydrophobic interactions of the entire 
system of lipids and proteins in the membrane. This involves seques­
tering not only the fatty acid side chains of the lipids from contact 
with water, but to the maximum extent possible, the nonpolar amino acid 
residues of the proteins as well. The interior hydrophobic region of 
the membrane must be highly compact with very few holes or gaps of 
atomic dimensions or larger. (3) Potential hydrogen bond donor and 
acceptor groijps of proteins which are sequestered from contact with 
water should form hydrogen bonds with one another to the maximum extent 
possible. 
The major drawbacks in structiiral features of the Davson-
Danielli-Robertson (D-D-R) Model are as follows; (l) The ionic heads 
of phospholipids are largely not in contact with the bulk phase 
(aqueous), but rather with the polar and ionic groups of the protein 
monolayers. To account for the fact that most membranes consist of 
proteins and lipids in a weight ratio considerably greater than unity, 
the spread protein must essentially completely blanket the ionic heads 
of the phospholipids. (2) The proteins and lipids interact with one 
another and the membrane is stabilized, primarily by electrostatic 
forces between their ionic groups. (3) The protein monolayers should 
exhibit a significant amount of jP-conformation (antiparallel pleated 
sheet) when not in a random conformation. (U) A significantly large 
fraction of the nonpolar residues of the proteins must be exposed to 
the water. In Robertson's work, evidence had been obtained only 
from myelin sheaths. (6) None of the evidence so far obtained for the 
bilayer form permits us to say whether the bilayer is continuous or 
interrupted. (7) None of the experiments are sufficiently sensitive 
and quantitative to prove whether 100 percent of the phospholipid is 
in the bilayer form. It is therefore not excluded that some signifi­
cant fraction of the phospholipid (perhaps as much as 30 percent) is 
physically in a different state from the rest of the lipid. 
It follows that this is not an arrangement which would lead to 
the lowest free energy of a membrane in its aqueous environment. The 
two most serious thermodynamic problems arise because (a) the nonpolar 
residues of the membrane proteins are largely exposed to, instead of 
being sequestered from contact with, water molecules, and (b) the 
ionic groups of the lipids and proteins are largely in contact with 
one another and out of contact with water; "the burying of the ionic 
grovips in a lower polarity environment is very costly in free energy" 
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(152). The D-D-R Model, therefore, is thermodynamic ally \mlikely. The 
fianction of lipids appears to be to disperse and "solubilize" membrane 
proteins by a kind of detergent action, in which the hydrophobic pro­
teins of the lipids and proteins interact with one another. 
In the case of Benson's Model, it appears that this is in too 
high a free energy state (but lower than that of D-D-R Model) to con­
stitute the general pattern of organization of most of the lipids and 
proteins of membranes. Intercalating most of the nonpolar fatty acid 
chains among the polypeptide chains in the interior of the membrane 
should, by virtue of separating the polypeptide chains, prevent the 
formation of the maximum number of interpeptide hydrogen bonds (which 
the fatty acid chains cannot participate in), and this would be thermo-
dynamically \insatisfactory. 
There is substantial evidence that the major portion of the 
phospholipids is in bilsyer form in a variety of intact membranes. 
The structures of the lipid in the membrane and of the lipid in iso­
lated aqueous dispersion are closely similar. This conclusion is 
st^jported by X-ray diffraction and spin label studies on similar mem­
brane preparations. So this bilsyer character of membranes rules out 
models such as that of Benson. 
Singer's Fluid l^fosalc Model. Essentially on the basis of 
thermodynamic considerations, together with some experimental data on 
the conformation of the proteins in intact membranes, Lenard and Singer 
(1^2, 1^3) proposed a hydrophobic model for the organization of the 
lipids and the integral proteins (the property that distinguishes 
integral proteins from others is its csqpacity to interact with lipids 
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in water solutions to fom lipoprotein structures with lower free 
energy than the separated lipid and protein) of the membranes. This 
model is also called, lipid-globular protein mosaic model. The lipids 
and globular integral proteins are arranged in an alternating mosaic 
pattern throughout the membrane. The hydrophobic portions of the 
lipids and a large fraction of the nonpolar amino acid residues of the 
proteins are sequestered from contact with water, mainly in the hydro­
phobic interior of the membrane, while the ionic groups of the lipids 
and the charged residues of the proteins are both in direct contact 
with water, predominantly on the exterior surfaces of the membranes. 
The saccharide groups whether on glycolipids or glycoproteins also are 
exposed to the bulk aqueous phase of this arrangement. Mosaic appears 
to be a fluid or dynamic one and, for many purposes, is best tho\ight 
of as a two-dimensional oriented viscous solution. This model is 
applicable to most functional biological membranes, 
Oseroff et al. (122) recently have sv^jported this model: that 
in most membranes the majority of the lipid is in the form of a fluid 
bilayer matrix, and that the membrane proteins are both loosely bound 
and, in some cases, deeply or transversely embedded in this matrix. 
Proteins and protein-lipid complexes are probably mobile, but it is 
not yet clear whether these motions result from passive diffusion or 
are actively conti'olled by the cell. Whether there exists a long range 
but random order is also unclear. 
Based on the results from freeze cleaving and freeze etching 
the trilamellar "unit membrane" described by Robertson (138) is not 
justified. Expeidments with labelled stearate bilayers (2^) and 
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examination of both halves of the fractured specimen (17, 173) have 
clearly establ3.shed that the cleavage plane tends to follovx the curva­
ture of the cell stirface but passes within the membrane matrix, probably 
in the midplane of the lipid bilayer. In most membranes the fracturing 
process exposes an array of particles; the density of the particles is 
greatest in functionally specialized membranes, such as, retinal discs 
and chloroplast lamellae; particles are completely absent in the myelin 
sheath. Other evidence that the intramembrane particles are due to 
proteins intercalated into a lipid bilayer comes from work vjlth arti­
ficial membrane systems. Pure lipid vesicles are lamellar phases and 
show an ^sence of particles, but they appear with the addition of 
erythocyte (130) and sarcoplasmic retic\iltun proteins (lOU) or with 
rhodopisn (62) which definitely seemed the material of choice. 
All these evidences point to the fact that Singer's model is 
the best model put forward so far. 
Mechanisms of Drug Absorption 
Absorption is the unidirectional movement of material from 
outside the body to the inside of the body. In man and other terres­
trial memraals, the alimentary canal, the Itmgs, and the skin represent 
the most important sites of entry for exogenous material. At each of 
these sites, the movement of material takes place across epithelial 
tissues that sei*ve as membranes or anatomical bari*iers. There are 
similarities in the overall processes of the translocation of materials 
at these seemingly diverse barriers; the mechanisms that serve to move 
materials across these membranes are those which serve to move sub­
stances across any biological barrter, i.e., passive diffusion. 
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facilitated diffusion, active transport, and pinocytosis; the pirinci-
ples governing these transport mechanisms apply equally at each site; 
and a substance passes through the membrane and reaches the other side, 
the vascular system, the gastrointestinal, alveolar or integumental 
epithelixim. On the other side of each of these barriers substances 
come in contact with fluids maintained at relatively constant composi­
tion, pH, and temper at vire, and having orderly biochemical interactions. 
Passive diffusion. Passive or simple diffusion does not require 
expenditure of cellular energy; movement occurs in proportion to the 
physical forces available, and in the same directions as the electro­
chemical gradient (diffuse from a region of high concentration to a 
region of low drug concentration) (7, 8U). Most pharmacologically 
important lipid-soluble drugs are transported across the biological 
membranes by this process. 
Gastrointestinal epitheli\im, like other biological membranes, 
is essentially lipid in nature. Therefore, it permits the passive 
diffusion of lipid-soluble drugs but imposes a barrier to the diffusion 
of lipid-insoluble drugs. Since most drugs are weak acids or bases, 
they can exist in both the undissociated and dissociated forms in an 
aqueous environment. The degree of dissociation depends on the pH of 
the medi\im and the dissociation constant of the drug. Since it is the 
undissociated form of the drug that has greater lipid solubility and 
hence is the more readily absorbed form of the drug, the rate of 
gastrointestinal absorption of weakly acidic or basic drugs is related 
to the fraction of total drug in solution in un-ionized form. The rate 
of ^sorption is enhanced when pH conditions are changed so that this 
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fraction is increased. These observations form the basis of the pH 
partition hypothesis (6l, lUU, l5l), which relates the dissociation 
constant, lipid solubility, pH at the absorption site with the absorp­
tion characteristics of various drugs throughout the gastrointestinal 
tract. 
Since the stomach has a low pH, weakly acidic drugs (pKa^2.5) 
exist primarily in the uii-ionized form and are readily absorbed. Con­
versely, weak bases exist primarily in the ionized form, and their 
gastric absorption is negligible. Partially dissociated (very weak) 
bases (pKa< 2.5) such as antipyrine and caffeine are absorbed to some 
extent. Additional evidence that it is mainly the non-ionized form of 
the drug which crosses gastric eptheliiim was provided by Schanker et al. 
(lU5) who demonstrated it by the reversal of the ^sorption pattern 
when the gastric contents were made alkaline (pH 8.0). Many basic 
C0iT530unds become undissociated at this pH and show an increased absorp­
tion rate; conversely, acidic compounds become more ionized and shov; a 
decreased rate of dDsorption. The preferential permeability of the 
gastric mucosa to the non-Ionized form of drugs is further eirphasized 
by the predictable manner in which drugs distribute between gastric 
jtiice arid plasma. Thus, at a steady state (constant plasma levels), 
basic drugs are more concentrated in gastric juice than in plasma, and 
acidic drugs are more concentrated in plasma than in gastric juice (l^l). 
The pH of the fl\iid of the small intestine is approximately 6.^ 
and is quite high con^jared to the stomach, but it behaves like the 
stomach in the absorption of drugs. Most weak acids and bases are 
readily absortedj stronger and more highly ionized acids and bases are 
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more slowly absorbed; and completely ionized quatemaiy airimoni\im com-
potinds and sulfonic acids are very slowly absorbed. Since pH is high 
in the intestine, the absorption of weak bases is favored over weak 
acids, since a large fraction of the drug is in tin-ionized form. Still 
the absorption of weak acids with pKa values greater than 3 is quite 
rapid. The large mucosal surface area available for absorption in the 
small intestine appears to decrease the need for a large fraction of 
the drug to be present in the un-ionized form. For example, salicylic 
acid (pKa -^3) exists almost completely in the ionized form in the 
intestine, but the drug is relatively well absorbed from this site 
(1U9). The influence of pH on the intestinal absorption of weak acids 
and bases in rats has been shown by Brodie (l6) and Kakemi et al. (6U). 
Acidification of the intestinal fl\iids increases the fraction of the 
drugs present in the un-ionized form and the absorption rate of weak 
acids, and decreases the fraction of the drug in the \in-ioivLzed form 
and the absorption rate of vzeakly basic drugs. 
It has been suggested by Hogben and Schanker (6l, lU^) that the 
pH of the bulk contents of the gastrointestinal tract is not a true 
index of the pH on the absorbing surface. It is proposed that a zone 
with an effective or virtual pH of ?.3> possibly located at the surface 
of the intestinal epithelivim, determines the degree of ionization of 
drugs as they spproach the boundary to be absorbed. 
The pattern of drug absorption in the colon is very similar to 
that in the small intestine. However, this is not the prime site of 
absorption for most drugs. 
Gastrointestinal absorption of drugs is influenced not only by 
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the degree of ionization but also by lipid solubility in the tm-ionized 
form. An indication that lipid solubility is the physical property 
goveniing the passage of un-ionized molecules across the gastric epi­
thelium has been provided by the barbiturates and the lipid-water 
partition coefficients of their un-ionized form (1U8). Kakemi et al. 
(66) also have shown sixnilar correlation of partition coefficients 
with absorption rate of various barbitvirates. With a homologous series 
of coirpounds this correlation of lipid solubility and absorption rate 
is very significant, but the ability to make predictions concerning an 
expected degree of absorption of an individual compound on the basis 
of its partition coefficient is indeed very limited. Despite this 
fact, it is in general true that compounds which are highly soluble 
in lipids are rapidly absorbed and those that are relatively less 
lipid soluble are more slowly absorbed when no specialized mechanism 
is involved in their absorption. 
Facilitated diffusion. Like passive diffusion this does not 
reqtdre cellular energy, and movement occTirs only with the electro-
chem3.cal gradient. It differs from passive diffusion in that the 
physico-chemical properties of the constituents of the membrane and 
those of solute are ins\ifficient to describe the kenitics of the pro­
cess, Therefore, the additional concept of tenporaiy combination of 
the solute with a chemical structure or site, "carrier," of the mem­
brane must be evoked to e^qilain the total phenomenon (8ii). There is 
increasing evidence that the protein present in the membrane plays an 
important role not only in structure but in fiinction, and that proteins 
are intimately involved in membrane transport (12^, 1^2, 153> 175). 
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Active transport. This process, while resembling facilitated 
diffusion in that the process requires the additional concept of 
carrier mediated passage across the membrane, is clearly distinguished 
from facilitated and passive diffusions by the fact that a net fltLX, 
or movement, of the solute must occxir in a direction opposite to that 
of the electrochemical gradient of the absorbed species. This active 
transport requires an energy source for the work to be done in moving 
the solute "uphill". This process permits the cell not only to control 
the rate at which substances move into, or out of, its environment, as 
does facilitated diffusion, but also to control the concentration of 
the specific substances inside and outside the cell. Pardee (12^) and 
Whitman and "Wheeler (17^) have reviewed the progress made to isolate 
these "carriers" in active tranqjort processes. 
The various active transport processes known to exist in the 
gastrointestinal tract are primarily associated with the absorption of 
nutrtents and food digestion products (3^, 1U6). Evidence of drugs 
absorbed by an active transpoirt mechanism appears to be limited to 
those agents that bear close similarity to normal body constituents. 
For example, certain serine and threonine derivatives of nitrogen mus­
tard and derivatives of uracil and thiamine (e.g., 5-fluoracil) have 
been sho\m to be transported across the intestinal epithelium against 
concentration gradients by processes that transport the parent amino 
acids and pyrimidines, respectively. 
Pinocytosis. This transfer mechanism also requires the expen­
diture of cellular energy. It differs from active transport in that 
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the transport of a solute, or particulate matter, is not mediated by 
combination with a carrier but by the local invagination of the cell 
membrane and subsequent budding off of a vesicle containing the perme-
ant. The poisoning by botulin toxins and allergic reactions resulting 
from the ingestion of offending proteins are well known exauqjles in 
htmans. 
CHAPTER II 
SURVEY OF LITERATURE 
Rarely a drug is used in the form of a pure substance. In 
pharmaceutical products a drug is generally combined with different 
types of adjuvants. Surfactants are one of the most important groups 
of the adjuvants used for diverse reasons in almost every dosage form 
including liquids, semisolids, and solids. 
Since these agents could affect the integrity of the biological 
membranes, it has been thought that they might be effective absorption 
promoters. However, it has been foimd that enhancement as well as 
inhibition of absorption takes place when surfactants are added to a 
drug. Blanpin (13) and Ritschel (136) have reviewed and summarized 
many of these reports. As noted by Levy (85), the difficulty in inter­
preting some of these studies probably has been due to different types 
of effects which surfactants can exert. Briefly, these effects include 
interaction with biologic membranes and change of permeability, inter­
action with the drug, interaction with the dosage form, and interaction 
with the organism itself, resulting in a pharmacologic effect which 
may, in turn, influence drug absorption. Several of these effects may 
be operative at the same time, some tending to enhance drug absorption, 
others tending to retard it, and the net effect being dependent on the 
relative magnitude of each. Gibaldi and Feldman (U9) have also recently 
reviewed the major mechanisms of surfactant activity. 
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It Is currently believed that sm-factants influence the rate 
and extent of drug absorption through one or more of the following 
mechanisms: (l) effect on drug solubility and dissolution rate, (2) 
effect on gastric ernptying time and intestinal motility, (3) surfactant 
and drug interactions, and (U) change in permeability of membranes. 
The literature reports pertinent to these mechanisms are discussed 
below. 
Effect of Surfactants on the Solubility 
and Dissolution Rate of Drugs 
When a drug is administered orally in solid dosage form it 
dissolves in the fluids around it; the drug in the solution form is 
then absorbed by different processes, depending upon its own nat\ire 
and the conditions around it (e.g., pH, food, surfactant, etc.). For 
drugs which have limited solubili-ty in the booty- fluids at the absorp­
tion site, the dissolution rate of the drug becomes the rate-limiting 
step in their absorption. If the dissolution process at the solid-
liquid interface is rate limited by diffusion from the very thin layer 
of saturated solution at the solid surface into the bulk liquid, then 
Noyes-^i/hitney (equation 1) and Noyes-Nemst (equation 2) equations are 
valid: 
II = K(Os - C) (1) 
where dC/dt is the dissolution rate of a drug, Cg is its sat\irated 
concentrations, C is the concentration at the time t during dissolution, 
S is the s\irface area of the solid, D is the diffusion coefficient, h 
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is the thickness of the diffusion layer, and V is the volume of dis­
solution medium (77)• 
According to dissolution theory, two important parameters 
determining the rate of dissolution of a solid in a given solvent sys­
tem are; the solubility of the drug in that system, and the surface 
area of the drug exposed to it. It can readily be seen from equations 
(l) and (2) that, for relatively water-insoluble drugs, the solubility 
term Cg is one of the most in^jortant factors governing the rate of 
dissolution. Therefore, any change in the dissolution media wiiich 
•v/ill effectively increase should, in theory, increase the dissolu­
tion rate of the drug. One means by wliich this can be, and is accom­
plished, is by the addition of a surfactant to the dissolution media. 
The mechaiisms by which surfactants increase the dissolution 
rate of a relatively water-insoluble drug are by decreasing the inter-
facial tension between the drug and the dissolution medium, thus 
alloTTing the latter to wet the drug more conpletely and/or by means of 
micellar solubilization. The latter mechanism involves the incorpor­
ation of the water-insoluble material into micelles (aggregates com­
posed of monomers of the surfactant) formed above the critical micelle 
concentration (CMC) of the surfactant (8). The enhanced solubility of 
a drug in a micellar solution of surfactant should result in a propor­
tional increase in the dissolution rate. TiiJhile exact proportionality 
is never realized in practice (because of the failure of the Noyes-
V;hitney equation to account for changes in the effective diffusion 
coefficient of the drug), the increase in apparent solubility will 
usually resxilt in an increase in dissolution rate (ii9). 
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The dissolution rate of a dru^, regardless of the dissolution 
mediTom, is always directly proportional to the effective stirface area 
of the drug avail^le to the dissolution medium. The effective siirface 
area of a drug is usually much smaller than the specific surface area, 
which is an idealized in vitro measurement. Many drugs whose dissolu­
tion characteristics cotild be improved by particle size reduction are 
extremely hydrophobic and may resist wetting by gastrointestinal flxiids. 
Therefore, the gastrointestinal fluids may come in intimate contact 
with only a fraction of the potentially available surface area. The 
effective surface area of hydrophobic drugs can often be increased by 
the addition of a surfactant to the formulation, which functions to 
reduce the interfacial tension between the solid and the gastrointes­
tinal fluids. Reduction in interfacial tension permits more intimate 
contact of drug and fluids, thereby increasing effective surface area 
and dissolution rate (U9). 
Importance of dissolution rate in the absorption of drugs is 
reflected in the observation by Wagner et al. (170) that blood levels 
after oral administration of four different commercial brands of 
warfarin showed a strong correlation with their in vitro dissolution 
rates. Bass et al. (6) have shown that availability of tetracycline 
is decreased almost ^0 percent from commercial capsules when 2 gm of 
sodium bicart)onate was administei?ed at the same time. When tetracy­
cline was dissolved prior to administration, no differences in avail­
ability were observed with or without the concomitant administration 
of sodium bicarbonate, indicating that the dissolution rate step is 
involved in the decreased absorption of tetracycline capsiiles. The 
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biologic availability of several conimercial digoxin tsiblets of known 
low and high therapeutic potencies and of digoxin dissolved in alcohol 
was studied in digitalized patients and compared with the dissolution 
rates of the tablets (l6l). Biologic availability was estimated by-
measuring the area beneath the plasma digoxin cxirve. The bioavail-
dDility of the "low potency" t^let was markedly inferior to that of 
the "high potency" tablet, which did not differ significantly from that 
of digoxin in alcoholic solution. A significant correlation between 
bio avail ̂ility and the dissolution rate was found. Llndenbaum and 
Butler (92) have also studied the bioavailability of digoxin tablets 
in humans after single 0,5 mg doses and in the steady state after 8-10 
days of drug administration. Excellent correlations were observed 
between dissolution rate and bioavailability. Variation in digoxin 
bioavailability appears to result from differences in the rate at which 
the tablets go into solution in the gastrointestinal tract. The U.S.P, 
XVIII interim revision has recently changed the reqtiirements from a 
disintegration test to a dissolution rate test for digoxin t^lets 
based on the ^ove findings on bioavailability data. 
Kellner (79) showed that higher blood cholestrol levels in 
rabbits could be achieved by administering cholestrol and polysortiate 
80 than by administeiring cholestrol alone. The reason for this marked 
increase in cholestrol absorption could be the increased dissolution 
rate of the water-insoluble compound. Allawala and ftLegelman (2) found 
the activity of solubilized iodine preparations, using polyoxyethylene 
glycol nonylphenal as the solubilizing agent, also to be controlled by 
the concentration in the aqueous phase which, in turn, depends on the 
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relative concentrations of iodine and surfactant and the distribution 
of iodine between the micellar and aqueous phases. Fuchs and Ingel-
finger (U?) found that sodium lauryl sulfate hastened the appearance 
and increased the levels of vitamin A in the blood of humaii subjects. 
It has been reported that the absorption of carotene (a precursor of 
vitamin A) is more rapid when solubilized in solutions of polysorttate 
80 than -when administered orally or intramuscularly in oil (16?)• Sobel 
(1^7, 1^8) has revealed inproved absoiption of vitamin A itself when 
in solubilized form; the transfer of the vitamin to the milk of nursing 
mothers is stKjerior in such case. Kakemi et al. (69) also have shown 
that the absorption rate of vitamin A from the rat intestine is in­
creased in the presence of polysorbate 80. MCtnzel observed that vita­
mins A, D and E were absorbed more effectively from sterile surfactant 
solutions than from oily solution on parenteral administration (112). 
Sodium lattryl sulfate improved the blood levels of griseofulvin (which 
is poorly and irregularly absorbed) (13U). The polyene antibioticj 
aii5)hotericin B, is poorly soluble in water at neutral pH. A soliibilized 
preparation, enqsloying sodium deocycholate as solubilizer gives better 
absorption and less pain than when administered intramuscularly as sus­
pension (31)« The percutaneous absorption of esterone is enhanced idien 
the steroid is solubilized in a surfactant. Using the potency of an 
oily solution injected subcutaneously as having an activity equal to 
1.0, Sjoblom (1^^) found the percutaneous activity in female mice of 
solubilized preparations containing moderate concentrations of surfac­
tants to be 0.36 ± 0.02 coTtQjared to a value of 0.13 ± 0.02 when solu­
tions of esterone in oil were \ised. Sjoblom (1^6) has also conducted 
studies on estradial-l? and found similar results. 
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Span 60 (sorbitan monostearate) and Atlas G-216U (polyoxyethy-
lene propylene monostearate) have been shovm to increase the absorption 
of sulf athiazole from a lanolin-petrolatum base (l^O). It is not 
possible to decide whether this is due to a solubilization effect or 
a simple miscibility effect. However, it is knoiwn that surfactants 
increase the solubility of soluble sulfonamides in ointment bases, 
^•fliitvrorth and Becker (176) have studied the effect of Arlacel 83 (Span 
83 or sorbitan sesquioleate) on the solubility of sulfacetamide sodim 
and s\ilfathiazole sodivan in liquid petrolatum and cottonseed oil bases. 
Arlacel 83 increased the diffusion of both drugs from the cottonseed 
oil base; from the petrolatum base the highest concentrations of the 
surfactant decreased the diffusion process. It is obvious that the 
solubility of a drug in the base is an important factor. Solubiliza­
tion of the drug in the bases will increase "Uie satoiration of the drug 
in the base, and will tend to promote its diffusion from the base, 
hence increase the absorption (31)* Incorporation of sodium la\iryl 
sulfate in G-strophanthin tablets resulted in an increase in absorption 
both rectally and orally in dogs, guinea pigs, rabbits, and rats. This 
is attributed to an increase in solubility and a higher rate of disso­
lution of the drug in the presence of the surfactant (36). G-strophan-
thin in a dose of 1 mg/kg, which has no effect on guinea pigs when 
given rectally, actually exhibits a toxic effect on addition of sodiiim 
lauryl siilfate (136). 
Addition of hydrophilizing agents to tablet preparations leads 
indirectly to improved absorption, since the stirfactants used not only 
lead, as a result of the in^iroved wetting, to faster dissolution and 
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hence to faster release of the drug from the preparation, but can also 
give better distribution (13^). Chodkowska and Krowozynski also fo\md 
the enhancing effects on absorption when siirfactants were included 
into a tablet formulation (l8). 
In some cases a surfactant msy inhibit the absorption of a 
compo-und by formation of a less soluble compound. Hudson et al. (63) 
reported that sitosteral and cholestrol formed a 1;1 mixed crystal or 
solid solution, which has a sol\ibility only one-third that of cholestrol 
in methanol, and a reduced solubility compared with cholestrol in 
aqueous sodium oleate or sodium deoxycholate solutions. This may 
possibly e:cplajji the hypocholestremic effects of sitosteral in human 
beings. Solubilization of salicylic acid (91), normally a well ab­
sorbed drug, led to a decrease in activity restilting from a lower level 
of absorption. 
Gantt et al. (h8) studied the influence of polysorbate 80 on 
the absorption of spironolactone when administered orally and found 
that the former markedly improved the absorption of the spironolactone; 
increase in dissolution rate due to solubilization and/or wetting ef­
fects is one explanation of the obseirved effects. However, changes in 
the formulation and manufacttire of the dosage form upon incorporation 
of the svirfactant may have been a factor in enhanced sibsorption. A 
study was performed by Cid and Jaminet (19) concerning the effect of 
some surfactants, such as polysorbate 80, on the gastrointestinal 
absorption of aspirin in man. A significant increase in blood levels 
of the salicylate was observed after administration of aspirin tablets 
containing the surfactant. 
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The behavior of stilfisoxazole in surfactant solutions has been 
studied by Kakenii et al. (72). V/hen sulfisoxazole was administered in 
the form of suspensions containing varying concentrations of polysor-
bate 80, it was found that the blood levels after one hour increased 
with increasing concentrations of the surfactant 153 to a maximum poly-
sorb ate 80 concentration of 20 percent, the concentration which com­
pletely solubilized the excess drug. Con^arisen of relative drug 
solubility in surfactant solutions and relative blood levels indicates 
that 18-fold increase in s\ilfisoxazole solubility in the presence of 
20 percent polysorbate 80 resulted in a threefold increase in initial 
blood levels compared to the level following the administration of the 
control suspension. Above 20 percent concentration of polysorbate 80, 
the rectal absorption decreased due to the entrapment of the driig in 
the micelles. 
Surfactants are often used as emulsifiers and solubilizers in 
oily base suppository formulations. Their addition is presiimed to 
affect the drug absorption to some extent from rectm. Kakemi et al. 
(75) have investigated the effect of various types of surfactants on 
rectal absorption of svilfisoxazole from cocoa butter. Blood levels of 
sulfisoxazole were, in general, increased with increasing concentrations 
of surfactant, but decreased with higher concentrations. Surfactants 
accelerated the release of the drug from the base to the medi"um, but, 
on the other hand, surfactants reduced the absorption rate of the drug 
from aqueous solution as noted earlier (72). The use of lipophilic 
Spans, either alone or in combination with hydrophilic Tweens, increased 
the release of active ingredient, aminopyrine, from suppositories (78). 
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Similarly, Parrott (126) has found that aspirin was rapidly released 
from suppositories of polyethylene glycol and polyoxyethylene sorbitan 
monostearate base. Hanks et al. (58) also investigated the influence 
the surfactants, polysorbates and sodium lauryl sulfate, on the release 
and activity of chloramphenical from the suppositories prepared with 
polyethylene glycol 1^00. Optimal activity and release were obtained 
with sodium lauryl sulfate. LovTenthal and Borzellaca (97) observed 
faster absorption v/ith Tween 6l in the investigation of the rectal ab­
sorption of salicylic acid from various suppositories bases. It has 
also been shovm in the case of barbiturates that the rectal absorption 
is increased by the addition of non-ionic surfactants (U3)« 
As mentioned before, relatively water-insoluble drugs are solu-
bilized by the process of micellization. Micelles containing a drug* 
when surrounded by the biological fl\iids, are able to release the drug, 
depending upon the partitioning behavior of the im-ionized species of 
the drug. Water-insolxible drugs, solubilized by micellization, are 
better absolved than when they are administered in the form of a sus­
pension or a solid dosage form, because of the slow dissolution rate. 
The phenomenon of micellar solubilization from the latter dosage form 
has been reviewed by Swarbrick (l6U) and Mulley (111). Elworthy et al. 
(31) have published a book on this subject. Numerous exanples have 
been cited of the pharmaceutical applications of micellar soliibiliza-
tion. 
A number of studies have attempted to quantitate the relation­
ship between drug solubility in micellar solutions and dissolution 
rates. Taylor and Wurster (I66) found that sodium dodecyl sulfate 
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svibstantiaJLly increased the rate of solution of prednisolone. Bates 
et al. (8) reported substantial increases in the dissolution rates of 
griseofulvin and hexestrol in micellar solutions of bile salts. Bates 
et al, (9) have also shown that physiologic concentrations of lysol-
ecithin produced marked increases in the solubility and dissolution 
rates of hexestrol, dienestrol, and griseofulvin. Kuroda (83) noted 
that the poor rate of dissolution of benzoic acid is improved in the 
presence of polysorbates 20 or 80. Parrott and Sharma (12?) have also 
found increase in the dissolution rate of benzoic acid in the presence 
of surfactants: tyloxapol, polysorbate 80, sodium lauryl s\ilfate and 
polaxakol. These surfactants only slightly improved the dissolution 
rate below their critical micelle concentration (CMC) due to improved 
wetting of surface. But at concentrations exceeding the CMC, the dis­
solution rate increased with increasing concentrations of the svirfac-
tants. Elworthy and Lipscomb (32) studied the dissolution rate of 
griseofulvin in water and aqueous solutions of foxir non-ionic surfac­
tants and found that the latter increase the dissolution rate of the 
drug. Gibaldi et al, (52) studied the influence of polyoxyethylene 
[23] lauryl ether, a non-ionic surfactant, on the dissolution rate of 
benzoic acid and salicylic acid and fotund that the dissolution rate 
was increased in the micellar solution. Influence of surfactant 
micelles (polyoxyethylene lauryl ether) on the dissolution of salicylic 
acid from constant-surface pellets has been studied (5l) and the rate 
of dissolution was found to increase. 
While the influence of micellar solubilization on dissolution 
rate has been st\idied extensively, the effect of low concentrations 
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(belov the CMC) of surfactants on the dissolution of drugs from powders 
and other solid dosage forms has been given limited attention. Finholt 
and Solvang (UU) studied the dissolution of phenacetin powder sprinkled 
on the surface of O.IN hydrochloric acid containing low concentrations 
of polysorbate 80. An increase in the polysorbate 80 concentration 
from zero to 0.01 percent causes a significant increase in the dissolu­
tion rate. The effect of polysorbate 80 on the dissolution rate of 
phenacetin is caused mainly by its ability to reduce the interfacial 
tension between the powder and the dissolution meditam. Prescott et al. 
(131) have also studied the effect of polysorbate 80 on the absorption 
of phenacetin in humans given in the forms of suspensions and tablets. 
In separate expei*iments individuals received phenacetin as a fine sus­
pension with and without polysorbate 80, a medium suspension, and a 
coarse suspension. They found striking differences in the plasma con­
centrations of phenacetin depending on particle size administered. 
The highest values were observed with the fine particles suspended 
with polysorbate 80, followed in decreasing order by fine, medium, and 
coarse particles. They concluded that pairticle size is an important 
factor in the absorption of phenacetin, and also that absorption is 
apparently enhanced by polysorbate 80. 
Vfeintraub and Gibaldi (17U) have studied the influence of 
premicellar concentration of a non-ionic surfactant (polyoxyethylene 
lauryl ether) and a physiologic surfactant (lysolecithin) on the dis­
solution rate of drugs from powders and from commercial dosage forms. 
Polyoxyethylene lauryl ether and lysolecithin increased the dissolution 
rate of powdered salicylic acid, and sodium glycocholate increased the 
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dissolution rate of powdered salicylsmide. In each case the effect 
principally involved a "wetting" phenomenon rather than solubilization. 
Both the non-ionic surfactant and lysolecithin enhanced the dissolution 
rate of aspirin from a tablet dosage form but were without effect on 
the dissolution rate of the drug from a capsule dosage form. 
Effect of Surfactants on the Gastric 
Emptying Time and Intestinal 
Motility 
In view of the qualitative and quantitative differences between 
the absorption properties of the stomach and intestine, any delay in 
the transfer of a drug from stomach to intestine may affect the absorp­
tion rate and, thereby, the onset of therapeutic activity. For example, 
a weak base such as codeine will be absorted mainly from the small in­
testine rather than from the stomach, and any delay in gastric emptying 
will tend to delay the onset of analgesia. Slow gastric emptying can 
also affect the biologic availability of drugs that are vinstable in 
gastric fluids, the extent of degradation being proportional to the 
time during which such drugs are exposed to low pH or gastric enzymes 
(8^). The effect of pharmaceutical formulation ingredients on the 
dissolution rate of weakly acidic drugs often will be most noticeable 
while the drugs are in the stomach, where ordinarily they dissolve 
relatively slowly. Such differences msy disappear when the drugs reach 
the small intestine, where dissolution is more rapid and less affected 
by differences in properties of the dosage forms (87). 
Delay in gastric emptying, on the other hand, can also cause 
increased absorption of a drug; an example has been provided by the 
work of Levy and Jusko (88). They found that administration of 
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riboflavin in hxanan subjects after a test meal increased the urinary 
recovery of the vitamin. Riboflavin is apparently absorbed by a 
specialized process high in the jejumum. Since the absorption process 
for riboflavin is capacity limited, the rate at which the vi tamin 
passes the absorption site may have an influence on the overall extent 
of absorption. These workers postulated that since a meal reduces the 
rate of gastric emptying, the rate at which riboflavin reaches the 
absorption site is also reduced, resulting in an increase in the ab­
sorption of the vitamin, 
Siirfactant macr influence gastric eit^tying rate by direct action 
on the stomach. Hardt (59) found that when sodium lauryl sulfate was 
introduced in certain doses in solid or solution form into the stomachs 
of dogs, it produced coif^jlete inhibition of nomal gastric motility for 
periods ttp to 90 minutes. 
Surfactants m?y also influence gastric emptying rate and intes­
tinal transit by physically altering the viscosity of the gastro­
intestinal fluids. Okuda et al. (121) studied the effects of non-ionic 
surfactants on the intestinal absorption of vitamin 82^2* They found 
that three of the surfactants studied enhanced the gastrointestinal 
absorption of the vitamin when the surfactants were administered \in-
diluted in high doses. This enhancing effect of polysoi^ate 80, poly-
sorbate 85 (polyoxyethylene sorbitan trioleate), and G-IO96 (polyoxy-
ethylene sorbitan trioleate) was postulated to be due to the formation 
of a highly viscous mass in the gastiric and intestinal lumen which 
resulted in a del^ in gastric erptying and thus increased the gastro-
ijitestinal absorption of vitamin Bi2» 
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A stirfactant rascy also exert a specific pharmacologic effect on 
the gastrointestinal tract which may influence drug absorption. Dioctyl 
sodium sulfosuccinate (DSS) retards gastric emptying (9U) and has an 
inhibitory effect on gastric secretions, even when administered in 
relatively low doses. Inhibition of gastric secretions occurs when 
the drug is administered intraduodenally, but there is no effect when 
contact of the drug is limited to the lumen of the stomach or when it 
is administered parenterally. It has been suggested by the author (9U) 
that the inhibitory effect of DSS is mediated by a hormone released 
from the intestinal mucosa, e.g., enterogastrone. Inhibition of gas­
tric motility in the dog following introduction of certain detergents 
into the gastric pouch was found by Necheles and Spom (11$). 
The influence of bile salts on gastrointestinal motility has 
also been studied. Pannett and Wilson (12U) have reported that the 
addition of a small quantity of sodium taurocholate to a test meal is 
folloi-ied by an ^normally rapid evacuation of the stomach contents. 
They also fotind an increase in the secretion of acid in the presence 
of the bile salt. Saski (lUO, lUl) reported the effects of orally ad­
ministered bile salts on the motility of the rabbit gastrointestijial 
tract. It was found that the effects of bile salts on gastric motility 
were extremely variable, with a slight increase in motility noted at 
low doses and a small decrease in motility at higher dosage levels of 
bile salts. The effect of bile salts on intestinal motility also was 
of a small order of magnitude (lUO). The bile salts usually produced 
a small increase in motility (lUl). Feldman et al. (38) have reported 
the effect of orally administered bile salts on gastric emptying in 
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the rat. Using phenol red as a marker substance, it was found that 
sodium deoxycholate and soditun taurodeoxycholate significantly de­
creased gasti*ic enqjtying of the phenol red solution. Gastric emptying 
of phenol red in control animals was found to proceed by apparent first 
order kinetics, but a very different kinetic pattern was observed upon 
administration of bile salt. Sodium deoxycholate and sodium tauro­
deoxycholate also produced a large net secretion of fliiids into gastric 
pouch for at least one hour after stomach intubation. It is proposed 
that the resulting increase in gastric volume is the immediate cause 
for the decreased rate of gastric emptying (Ip.). Mayersohn et al. (103) 
investigated the gastrointestinal absorption of riboflavin and flavin 
mononucleotide (FMI) under controlled conditions and after oral admin­
istration of 600 mg of sodium deoxycholate. Increased urinary excretion 
levels suggest an unusually prolonged absorption of riboflavin which 
may be due, in part, to a decrease in gastric emptying time. 
Smrfactants and Dinig Interactions 
A significant change in the ability of a drug to permeate a 
biologic membrane may result from an interaction of the drug molecxile 
with the surfactant to form a molec\ilar complex. A molecTilar complex 
consists of constituents held together by weak forces, such as hydrogen 
bonds. This type of interaction is usually reversible, provided that 
the complex is sufficiently soluble in the biologic fluids. The 
properties of drug complexes, including solubility, molecular size, 
diffusiveness, and lipid-water partition coefficients, can differ 
significantly from the properties of the respective free drugs. These 
differences are responsible for the fact that many drug complexes 
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cannot penetrate biologic membranes, and therefore, have no biologic 
activity. In such cases, the fraction of drug in the complex, which 
is in equilibrium with the non-complexed drug, will be in an essen­
tially nonabsorbable form and the effective concentration of drug will 
be less than the total concentration. 
In sinple solutions the antibacterial activity of the phenol 
is logarithmically related to its concentration, but in solutions con­
taining surfactants at concentrations high enough to form micelles, 
the activity is not related to the overall concentration in solution 
because the micelles compete with free water for phenol so that only 
part of it is available for interaction with bacteria. The effect ma?/-
be regarded as a partition phenomenon, so that the concentration of 
the phenol in aqueous phase depends on the "partition coefficient" of 
the phenol and the ratio of the volume of the micellar "phase" to the 
aqueous "phase" (ill). 
Below the CMC the activity of phenols is dramatically increased 
by the surfactants. This seems to be due to the increased tptake of 
the phenol on the biologic menibrane by the high surface activity of a 
loose cor5>lex between the phenol and the surfactant. The perme^ility 
of the bacterial surface may also be increased in the presence of 
surfactant. In systems where the concentration of stirfactant is kept 
constant (above CMC) and the concentration of phenol is increased 
(i.e., capacity of the system is fixed) one would expect activity to 
increase regularly since both micelles and aqueous "phase" are being 
progressively saturated with the phenol. This expectation has been 
proved by the work of Berry and Briggs (11), who have shown that all 
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phases in a system like this will be in eqtiilibri"um and the concentra­
tion of phenol "free" in the aqueous phase will increase in the same 
proportion as that in the micelles. A gro'i-rbh inhibition study of hex-
etidine (bis-1, ̂ -ethylhexyl-5-amino-5-methyl [hexd^ydropyrinidine]) 
carried out in the presence of pluronic F-68, L6Li and L62 showed that 
the activity was enhanced below the CMC of pl\ironic F-68 and l6U 
(pluronic L62 had no effect at any concentrations) and above the CMC 
the activity of hexetidine was reduced by the former compounds (lU2). 
Another exanple of interaction of surfactant with the drugs is 
that of iodophors. For many purposes solutions containing 1 to 2 per­
cent of iodine are used, solubilized by a suitable proportion of the 
siirfactant, usually the non-ionic type. Allawala and Riegelman (2) 
have shown that the proportion of iodine solubilized changes propor­
tionately with the concentration of the surfactant (nonyl phenol 
polyglycol ether-Antarox A-UOO). The same authors found that the 
activity of solubilized iodine depended on the amount in the free 
solution which is controlled by the proportion of iodine to the sur­
factant and the "distribution coefficient" of iodine between micelles 
and the aqueous phase. 
Preservatives, like the p-hyxiroxybenzoates, have far greater 
activity in aqueous solutions of surfactants below and up to their CMC, 
but activity decreases dramatically beyond this point; same phenomenon 
takes place as described above. Bolle and Mii*imanoff (lU) were the 
first to point out the reduced effect of methyl-p-hyxlroxybenzoate in 
the presence of several structurally different non-ionic surfactants. 
De Navare (27) followed vp this work and in 19^7 remarked that 
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practically an non-ionic surfactants based on ethylene and propylene 
oxide condensed with each other or with fatty esters, alcohols or 
acids, inactivate all the preservatives considered at that time suit­
able for drug and cosmetic preparations. This has been confirmed by 
other workers (171). Non-ionic surfactants have been found also to 
reduce the effect of quaternary ammonium compounds (137). Activity of 
organic mercuiy conpounds is also markedly reduced in the presence of 
non-ionic siirfactants (171). The inactivating effects of non-ionic 
surfactants on the preservatives are of greater significance than those 
of other types of surfactants because not only is the order of their 
inactivation much higher, but, unlike the other surfactants, non-ionics 
have comparatively no groirth-inhibiting properties, making the neces­
sity for adequate preservation of systems containing them much greater. 
Wedderb\im (172) has summarized the evidence relevant to estab­
lishing the mechanism or mechanisms by which these preservatives are 
inactivated in relation to their interaction with non-ionic surfactants. 
Mcellar solubilization and the formation of molecular coirqplexes of the 
type described by Higuchi et al. (60) have both been proved as being 
responsible for their inactivation. \^ile complexation is thought to 
be important in some systems, Evans (3U) has ST:^gested that the most 
important factor is micellar solubilization when the non-ionic surfac­
tant concentration exceeds the CMC. The antimicrobial activi-ty of 
preservatives in such systems has been shown to be directly related to 
the concentration of free unbound preservative (172). 
Cationic forms of chlopromazine, promethazine, tetracaine, and 
methylrosaniline, and anions such as naphthalene sulfonate were bound 
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•bo polysorbate 80, the degree of interaction being sufficient to suggest 
that the non-ionic might have considerable influence on the st^ility 
and availdaility of ionic drugs in formulations (107). 
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Studies of the effects of neortgrcin and kanairycin upon intestinal 
absorption in normal but obese humans have sho-wn that both antibiotics 
produce steatorrhea and are able to reduce their own intestinal absorp­
tion due to the formation of insoluble, nonabsorbable precipitates with 
bile salts (37). Kakemi et al, (6$) studied the effect of sucrose 
esters and other sxirfactants on the absorption of various drugs using 
perfusion technique on the rat small intestine. Tetracycline, sulfa­
nilamide, isoniazid, and salicylic acid were used to test drugs and 
sodium lauryl s\ilfate, benzethonium chloride, polysorbate 80, sucrose 
monostearate, and sucrose distearate were the surfactants used. It 
was found that ionic nature of the surfactants substantially influenced 
the absorption; rate of absorption of tetracycline was accelerated by 
soditim lauryl sulfate, benzethonium chloride, and sucrose esters; poly-
sorb ate 80 showed a marked reduction in the absorption of salicylic 
acid and tetracycline; benzethonium chloride reduced the absorption of 
salicylic acid and sucrose esters within different concentrations 
tested did not reduce the absorption of all the drugs tested. These 
were explained due to the formation of complexes or other forms of 
interactions and/or by the correlation of partition coefficients. 
Malone et al. (99) found a significant increase in the pharma­
cological activity of reserpine in mice after oral administration of 
the drug as a solid dispersion in deoxycholic acid. A correlation 
between the conposition of the reserpine-deoxycholic acid dispersion 
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and biologic activity vras also noted in that an increase in the 
deoxycholic acid ; reserpine ratio resvilted in an increase in bleph-
aroptotic activity. Gibaldi et al. (h9) suggested, on the basis of 
dissolution rate studies of this system (deoxycholic acid : reserpine), 
that pajrticle si7€ reduction of reserpine in the dispersions, leading 
to increased dissolution and absorption rate, and possibly increased 
availability of reserpine, is likely to be a major factor in the en­
hancement of pharmaxiologic activity. DeCato et al. (26) have also 
studied the reserpine-bile salts coprecipitates absorption in mice. 
It was shown that intravenous administration of reserpine acetate and 
oral deoxycholic acid showed no increase in blepharoptotic potency 
relative to Intravenous reserpine acetate alone. Since this experiment 
eliminated the physico-chemical interactions within the gastrointes­
tinal tract, the authors have concluded that the potentiation of 
reserpine taken orally as reserpine-bile salts coprecipitates is by 
physico-chemical rather than physiopharmacological means. 
Riegelman and Crowell (133) studied the effects of surfactants 
on the rectal absorption of iodoform, tri-iodophenol, and iodide in 
rats. Polysorbate 80 and sodlxim lauryl sulfate were foTjnd to decrease 
the rectal absorption rate of iodoform and tri-iodophenol, but to in­
crease the absorption rate of iodide. The decrease in rectal absorp­
tion rate of iodoform and tri-iodophenol was attributed to micellar 
complexation of the drugs, while the increase in iodide absorption 
rate was postiHated to be due to a cleansing action of the sxirfactant 
on the intestinal mucosal surface. Since iodide ion is lipid insoluble, 
it would not be expected to be incorporated into the s\irfactant micelles. 
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Retardation of iodoform and tri-iodophenol absorption in the presence 
of micellar concentrations of the sxirfactants is in accord with the 
following model: (a) a micellar solution consists of two phases, (b) 
the partition ratio of drug between micellar phase and the aqueous 
phase is constant, independent of drug concentrations, and (c) absoi*p-
tion of the drug incorporated in the micelle is negligible. Since the 
drug in the micellar phase is \inscvailable for absorption, the effective 
concentration of the drug is less than the apparent concentration, and 
a decreased absorption rate is observed. 
Levy and Reuning (91) studied the effect of micellar solutions 
of polysorbate 60 on the absorption of ethanol and salicylic acid from 
the rat gastric pouch. They found that in the presence of 2 percent 
polysorbate 60 the absorption of salicylic acid was decreased from 
percent in one hour to 33 percent in one hoTir, while ethanol absorption 
remained unchanged. The obseirved effect was due to a decrease in ac­
tivity of salicylic acid as a result of micellar complexation. The 
absorption of ethanol (which would not be incorporated into the sur­
factant micelles) was unaffected by the presence of surfactant. Kakemi 
et al. (72) studied the effect of various non-ionic surfactants on the 
rectal dDsorption of sulfonamides from solutions in the rat. At con­
centrations of the surfactant aibove the Cl-IC a reduction in the absorp­
tion rates of the sulfonamides was observed due to entrapment of drugs 
in micelles. Ionized sulfonamides are poorly solubilized in the 
micelles, but it is the un-ionized form which is biologically active 
and the \in-ionized form has distribution coefficient in favor of the 
surfactant micelles than the biological fluid. They also noted that 
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the ionized moiety of these drugs is also able to be absort)ed to a 
certain extent. Moroshita et al. (110) also found that the absorption 
from rat intestine of sulfonamides in the anionic form was quite sig­
nificant. Yamada and Yamamoto (l82) found similar effects of micellar 
solutions of polysorbate 80 on the intestinal absorption of salicyla-
mide in the perfused rat small intestine. Also, they observed no 
apparent effect of polysorbate 80 on the mucosal membrane, as deter­
mined by permeability expeirLments with salicylamide before and after 
a prolonged perfusion of the intestine with a polysorbate 80 solution. 
It is obvious that this technique can detect only irreversible effects 
on membrane permeability. Matsumoto (101) offered essentially the 
same mechanism of micellar solubilization and a corresponding decrease 
in free drug concentration to explain the effect of polysorbate 80 on 
the intestinal absorption of stilfisoxazole in the rat. Saski (lUl) 
studied the effect of micellar solutions of tyloxapol, a non-ionic 
svirfactant, on the transfer of hydrocortisone across everted rat intes­
tine. Drug transfer rate was inversely proportional to the surfactant 
concentration and the viscosity of the solution tested. The data sug­
gest that the membrane is in^ierme^le to the drug-micelle species. 
Utsumi (l68) found that sodium lauryl stilfate formed a complex with 
benzoylthiamine disulfide (BTDS) through ionic and hydropholic inter­
action, and decreased the absorption rate of BTDS from rat intestine. 
But it was fotaid later by the same authors that a system containing 
both sodituti lauryl sulfate and sodium glycocholate reversed the decrease 
in absorption rate of BTDS vq) to around the control level. By deter­
mining the saturation solubility of BTDS it was found that its 
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solubility in 0.2.% sodium lauryl sulfate solution was remark^ly re­
duced by mixing sodium glycholate in this solution. In this binary 
surfactant mixture an increase in the CMC value with decreasing parti­
tion coefficient for BTDS in the micelles was found in proportion to 
the increase in the ratio of sodium glycocholate and sodivim lauryl 
sulfate. The authors have concluded from this that sodium glycocholate 
contributes to creating new mixed micelles having a different partition 
coefficient from the drug (BTDS) than from those of sodixui lauryl sul­
fate micelles. The formation of mixed micelles and the ensuing in­
crease in the amo\ant of BTDS out of micelles are evidenced to be 
responsible for the sodium glycocholate effect which cancels the 
inhibitory action of sodium lauryl sulfate in the absorption of BTDS. 
Influence of Sm^factants on the 
Permeability of Membranes 
A nuniber of siobstances have been found to 'interact' with 
biological membranes and thereby alter permeability or transport char­
acteristics. Windsor and Cronheim (180) reported that heparan and 
s\ilfopolyglycine, normally very poorly absorbed from the gastrointes­
tinal tract, were absorbed to an apprecistole extent when axJministered 
together with the chelating agent, ethylenediamine tetra-ajcetic acid 
(EDTA). Schanker and Johnson (1U7) also observed an increase in the 
in vivo intestinal absorption of mannitol, inulin, a quaternary ammon­
ium conpovmd, and sulfanilic acid (all lipid insoluble compounds) in 
the presence of EDTA. Tetracycline has also been shown to interact 
with the biologic membrane mediated through calcium ions (67, 113). 
Tetracycline increased the absorption of sulfanilic acid and 
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sulfaguard-dine (llU). Nadai et al. (llU) have examined the histological 
changes occurring in the rat small intestine (using light microscope 
and scanning electron microscope) after administration of EDTA, which 
has absorption enhancing effect on the poorly absorbable drug. Marked 
separation of epithelial cells was observed but histological changes 
were not obseirved as viewed with light microscope. The role of calcium 
in maintaining the integrity of the intestinal membrane was affected 
by the chelating agent and the removal of calcium ion from the intes­
tinal mucosa caused such marked shedding of epithelial cells. 
Surfactants may also be cspable of modifying the properties of 
biologic membranes. Perhaps the earliest report of the effect of sur­
factant on drug activity is that of Billard and Dieulafe (12), who 
noted that the toxic effect of ctirare injected in traperi tone ally into 
guinea pigs could be increased by the addition of low concentrations 
of soap and decreased by high concentrations. Alexander and Trim (l) 
reported that the penetration of hexylresorcinal into Ascaris lunibri-
coides can be affected by cetyltrimethyl ainmont\im bi^mide (CTAB) in two 
different ways. Below the CMC the surfactant increased the penetration 
of the drug, and at concentrations above CMC, the penetration of the 
drug was reduced. Effect of surfactant below CMC is due possibly to 
the increased permedsility of the membrane surface. Levy et al. (89) 
studied the effect of polysorbate 80 on the absorption of a number of 
barbitiirates across the goldfish membranes. The absorption rate of 
barbiturates was found to increase significantly in the presence of 
low concentrations (below CJKJ) of the surfactant and to decrease at 
higher concentrations of the surfactant. Their fiirther studies (86) 
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showed that the increase in absorption rate of secobarbital at the 
concentrations of polysorbate 80 below the CMC vxas due to an increase 
in the permeability of the biologic membranes rather than to formation 
of a more rapidly absorbed non-micellar polysorbate: secobarbital 
conplex. The same authors (3) ha^e also shotm that pre-micellar con­
centrations of polysorbate 80 enhance the absorption and exsoiption of 
U-aminoantipyrine across the goldfish membranes. Gibaldi et al. (53) 
studied the influence of sodiura taurodeoxycholate on the pharmacologic 
effect (overt\im time) of pentobarbital and ethanol in goldfish. They 
found that bile salt significantly potentiated the pharmacologic effect. 
Ethanol can diffuse through the 'pores' of the membrane, while the 
barbiturate must diffuse across the lipoidal barrier; the non-ionic 
surfactant might have a specific effect on the lipoid content of the 
cell membrane and thus change its permeability. Further studies (11?) 
indicated that the bile salt exerts an all-or-none effect on the tiptake 
of U-amino an tipyrine in goldfish; an alteration in membrane permea­
bility was observed above a certain bulk concentration but below the 
C14C of the stirfactant. Whitworth and Yantis (177) found an increase 
in the absorption of salicylic acid across the external membranes of 
the frog in the presence of 0.1^ polysorbate 80. The effect of poly­
sorbate 80 on the biological activity of chloipromazine hydrochloride 
in solution was investigated by Florence (U5) using the goldfish. 
Below a certain critical concentration the activity was enhanced in 
unbuffered drug solutions, but above this concentration the activity 
was diminished, possibly due to some association between sxirfactant 
micelles and drug molecules. 
LI 
Hunan cornea has also been used to study the effect of surfac­
tants on absorption. In such a study (lOO) 0.1% solutions of non-ionic 
surfactants were used. The permeability of the cornea was measured by 
following the movement of the fluorescein dye. Only three surfactants 
(Tween 20, Brig and Brig 58) had any marked effect on the absorp­
tion of fluorescein. Tween 20 was the only coir^Jound that safely in­
creased the permeability of the corneal epithelium; the other two 
agents produced eye irritation. 
Nickel salts compounded with anionic stirfactants caused edema, 
but non-ionic and cationic siirfactants did not show this effect. This 
could be due to an acanthotic effect (modification of the prickle cell 
layer [strattmi germinativum] of the skin) or to the denaturation of the 
epidermal proteins by the anionic surfactants, allowing nickel salts 
to penetrate skin and cause eczema (l69). Scala et al. (lU3) in a 
study of the percutaneous absorption of ionic surfactants found that 
alkylbenzene sulfonates and dodecyltrimethyl ammonium chloride alter 
skin permeability as they diffuse into and through the skin. When 
nicotinate and thiourea were placed in the surfactant solution, the 
rate of diffusion of these coir^ounds was found to increase with time, 
similar to the diffusion characteristics of the surfactants themselves. 
Kay (78) found that the permeability of the Ehrlich-Lettre ascites 
carcinoma cells was increased greatly in the presence of polysorbate 
80 as sho^Tn by the tptake of Lissamine green dye. Percutaneous ab­
sorption was measured by immersing the hind foot of a mouse in a drug 
solution, then extracting the d3soit)ed drug. It was shown that poly­
sorbate 80 increased pyrrolnitrin sibsorption when a surfactant con­
centration of 0.01^ and 0,\% was used. 
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Appel (5) foiind that simultaneous feeding of sodium lauryl 
sulfonate and inulin to rats results in up to a tenfold increase in 
urinary excretion over control values. The enhanced urinary excretion 
of urine may be the resiJ.t of an increase in intestinal permeability 
to inulin in the presence of the surfactant. Mori et al. (109) found 
that rats and hamsters fed polysorbate 20 showed increased gastro­
intestinal absorption of iron. However, Brise (l5) in a later study 
reported that there was no effect of polysorbate 20 on iron absorption 
in man. He further postulated that the increase in the absorption of 
iron in hamsters and rats in the presence of polysorbate 20 by Moi-i et 
al. may have been due to some 'toxic' action of the surfactant. The 
absorption of barium chloride ingested by cats was promoted by both 
polysorbate 20 aid sodium lauryl sulfate at low concentrations and 
inhibited at high concentrations (1^9). 
Suzuiki et al, (162) found increased permeability, as measured 
by a circulating dye, at the site of an intracutaneous injection of 
various non-ionic surfactants. Authors postulated that this increase 
was mainly due to the wetting and solubilizing effects of the surfac­
tants on lipid structure of the capillary wall. Matsuzawa et al. (102) 
studied the effect of some non-ionic surfactants on the muscular ab­
sorption of endtiracidin. Addition of the surfactant remarkably pro­
moted the absorption of enduracidin from the muscles of the rats. They 
postulated that since the effects of surfactants are considered to be 
due to their interaction with both the biological membrane and the 
drug, therefore it is reasonable to sippose that one of the enhancing 
effects observed could be attributed to the surface tension lowering 
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of the biological raeiribrane, which allows the ready passage of the 
antibiotic through the muscles. 
Penzotti and Mattocks (128) found an increase in the rate of 
peritoneal dialysis of urea and creatinine in rabbits in the presence 
of siirf act ants. It was found that the order of magnitude of effects 
decreased in the following manner: cationic > anionic >> non-ionic. 
It appears that the mechanism involves a change in the permeability of 
the peritoneal membrane. 
Lish and Weikel (96) studied the effects of surfactants on the 
absorption of an anionic dye, phenolsulfonphthalein (PSP) from the 
colon of rats. Both sodium lauryl sulfate and dioctyl sodium sulfo-
succinate, but not the non-ionic Pluronic F-68, increased the absorp­
tion of PSP- None of the surfactants studied had any effect on the 
absorption of the cationic dye, methyl violet. Engel and RLggi (33) 
studied the effects of surfactants on the intestinal absorption of 
heparin in the rat. They found that intraduodenal administration of 
heparin with either sodium lauryl sulfate, dioctyl sodium s\ilfosuc-
cinate, or G-300 (an alkyl aryl sulfonate) resulted in an increase in 
heparin absoiption over that observed when heparin was administered 
alone. They also reported enhanced heparin absorption in the presence 
of O.U^ sodium taurocholate. The authors postulated that the increase 
in heparin absorption is due to an effect of the surfactant on the 
intestinal mucosa. Kakemi et al. (69) studied the absorption of solu-
bilized vitamin A (in surfactant) from the rat intestine. Contrary to 
the notion that the only form in which drug can penetrate the membrane 
is the free form of the dinig, both vitamin A acetate and vitamin A 
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alcohol, entrapped almost completely in the micelles, were absorbed 
fairly well from the small intestine, but not as from the large intes­
tine. It was demonstrated that in the very early stages of dasorption, 
vitamins sol\jbilized in micelles are absorbed onto the membrane, which 
is favored by the surfactant, and this results in a local build-up of 
concentration of the vitamins. This process makes the drug transport 
through the membranes. Kakemi et al. (70) studied the absorption of 
drugs from oil in water emulsions from the rat large intestine. It was 
found that in the case of poorly oil-soluble drugs the absorption was 
increased when administered in the form of emulsion; but in case of 
drugs of low lipophilicity the absorption was inhibited when emulsion 
volume was kept constant in both cases. 
Davis and Kreutler (2I4.) studied the effect of surfactants on 
the absorption of water-soluble substances from rats. Using labelled 
cyanocobalamin (^'''co) both gastric and intestinal absorption were 
markedly increased by the addition of Brij 98 (polyoxyethylene-20-
olelyl ether) to the aqueous solution of the vitamin. Absorption of 
cephaloridine and cephalothin was promoted both in ligated stomach and 
ligated small intestine. Using cholestrol monolayers Gillan and Flor­
ence (^U) have found that, in case of non-ionic surfactants, where the 
surfactant has long hydrophile chains (i.e., > ^ ethylene oxide units) 
rather than a single ethylene oxide chain or several short ethylene 
oxide chains, drug absorption rates would not increase. This indicates 
that the effectiveness of the surfactant is due to the ease with which 
the surfactant molecule penetrates lipid membranes. 
Bile salts hmre long been implicated in the intestinal 
absorption of fat and other nutrients. They are knov/n to have 
an important role in the eraulsification of water-insoluble, 
long-chain triglycerides and in stimulating the action of 
pancreatic lipase, resulting in a mixt\ire consisting of fatty 
acids, monoglycerides, diglycerides, and triglycerides. A 
powerful emulsifying agent is also formed by removal of a 
fatty acid moiety from a molecule of lecithin by a pancreatic 
phospholipase to give lysolecithin (I4.9). 
Bile salts have also been shown to be involved in the absorption of 
vitamins A, D, and K. Several reports have shown the effect of bile 
salts on the absorption of cholestrolj exogenous bile salts also en­
hance the absorption of cholestrol (U9). A recent report has sho^-m 
that bile salts increased about 25 percent the absorption of labelled 
dietary cholestrol fed to germ-free rats (177)• Longemann and Dobbins 
(U9) found that intraperitoneal injections and large oral doses of 
sodium taurocholate enhanced the absorption of calcium by the rat. 
Seyfried and Lutz (h9) reported that the absorption of tetraiodophen-
olphthalein from intestine was greatly diminished in the absence of 
bile salts. Pekanmaki and Sabin (U9) reported that the absence of 
bile from the intestine of cats reduced the absorption of phenolph-
thalein, Davenport (23) found that bile salts are capable of increas­
ing the perme^ility of the gastric mucosa as judged by hydrogen ion 
flux. ^Vhen sodium deoxycholate was administered 30 minutes prior to a 
dose of riboflavin, a ^0-80 percent increase in total urinary recovery 
was found. Two mechanisms were postulated by the authors: (a) reduc­
tion in gastric emptying time, and (b) increase in the permeability of 
gastric mucosa (103). Meli et al, (105) reported that endogenous bile 
influences the rate of intestinal eibsorption of an estrogen (ethynyles-
tradiol-6,7-%-3-cyclopertyl ether) in rats. The rate of ^sorption 
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of estrogen was considerably lower in biliary-cannulated rats than in 
control animals. Since the steroid is relatively water insolxible, the 
presence of bile salts might have increased the solubility of the drug 
in the intestinal Imen and thereby enhanced the dissolution and ab­
sorption rate. Levels of conjugated bile salts normally found in the 
proximal intestine alter the permeability of everted rat intestine to 
salicylate (39), salicylamide (38)* riboflavin (U3), and several other 
drugs. Nightingale et al. (Il6) studied the effect of bile flow on 
the absorption of s\ilfadiazine. They showed that bile flovr is an 
important factor in sulfadiazine absorption from the intestinal loops. 
Feldman et al. (IjO) studied the influence of sodixim deoxycholate on 
the absoiption of phenol red in the rat with different methods. Each 
of the methods provided evidence that the bile salt markedly enhanced 
the absorption of phenol red by altering the permeability of the intes­
tinal membranes. Kakemi et al. (73) studied the influence of sodium 
taurocholate and sodium glycocholate on the absorption of the same drug 
(phenol red). They postulated that there are three likely mechanisms 
by which bile salts can affect drug absorption from the rat small in­
testine; first, the loss of thermodynamic activity of a drug due to the 
formation of a micellar complex; second, the local concentration build­
up effect, such as accumulation on the ^sorptive surface; third, the 
direct effect on the permeability of the intestinal mucosa. Kakemi et 
al. (7U) also studied the influence of these bile salts on the intes­
tinal absorption of sulfaguanidine. They postulated that the enhance­
ment of absorption of drug was caused by the direct action of bile 
salts to the structure of the absorptive s\arface. 
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Some drugs like tetracycline and dextromethorphan (U2, 129) 
themselves possess surface activity and infl\ience their o"wn absorption, 
e.g., due to the anion's contribution to the suitTace activity in case 
of dextromethorphan salts (U2). 
Evidence has accumulated vrhich suggests that a drug's affinity 
for the intestinal wall may be an important factor in its transport 
across. In the study (71) of absorption of barbiturates a discrepancy 
from the pH-partition hypothesis vxas noted. This discrepancy was cor­
related significantly with the in vitro binding to mucusal preparations 
of rat small intestine. The sorption of a sxirfactant also takes place 
onto the intestinal wall and can also effect the absorption of drugs. 
Nogami et al. (120) studied the sorption of ionic sm-factants (sodium 
lauryl sulfate and cetyltrimethyl ammonim bromide) into the intestinal 
tissue of the rats. Kakemi et al. (68) studied the absorption of cer­
tain ion-pair complexes of some pharmaceutical amines vrLth soditun 
laxiryl sulfate and sodium saccharin. It was found that the enhancement 
of absorption of these drugs could better be related to the binding 
behavior of these drugs to the rectal mucosal preparations. Some 
authors, in order to confimi that the binding to the mucosa is an 
important factor in the absorption from small intestine, studied the 
binding of fifteen drugs with mucosal homogenates. Their experiments 
indicate that the binding of drug (both ionized and un-ioniaed) to the 
mucosa of the small intestine is important in absorption of drugs. 
They also mentioned that while absorption from rectum is consistent 
with pH-partition hypothesis, it is not so in case of small intestine. 
Suzuikl et al. (163) studied the absorption of qtiinine and chlorpheni-
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ramine from the gut given with various anionic agents (including sodium 
lauryl sulfate) which form ion-pair complexes. It was found that the 
increase of the drug binding to the absorptive membrane was responsible 
for the enhancement of the drugs present in the form of an ion-pair 
complex. The affinity of surfactants for hydrophobic surfaces and for 
interfaces in general leads one to expect that they will have a pro­
found influence on the behavior or condition of cell s\irfaces, which 
are predominantly hydrophobic in nature. Many cationic detergents have 
a non-specific disrupting effect on the cells of bacteria and tissue, 
thus precluding their systemic use. Nissim (119) studied the effect of 
feeding cationic, anionic, and non-ionic surfactants on the histology 
of the mouse gastrointestinal tract. He found marked pathological 
changes when the ionic surfactants were fed to mj,ce but no effects 
when non-ionic s\irfactants vrere tested. However, there is evidence 
that non-ionic polysorbate 80 disr\:5)ts membrane structure but there is 
a rapid reconstitution of cell membrane material after treatment (80). 
Triton X-100, an alkylphenyl polyether, totally disrupts lysosomes, 
m3.tochondria, and erythrocyt.es (26). Taylor (l65) studied the effects 
of cetyltrimethyl ammonivan bromide on transport and metabolism in the 
small intestine of rat. The surfactant was found to produce no histo­
logical damage to eveirted rat intestine sacs at lower concentrations 
of the surfactant. But at higher concentrations, concomitant with the 
mucosal damage, there was an inhibition of the transport of glucose, 
methionine and water. Nissim (ll8) had also found increased ^sorption 
of glucose with various surfactants at low concentrations. Kozlick and 
Mosinger (80) had observed that low nontoxic doses of sodium lauryl 
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sulfate increased the rate of absorption of glucose administered to 
rabbits. Kakemi et al. (72) also found that cationic surfactants, 
cetyltrimethyl anononium bromide and benzethoniuui chloride, caused sn 
increase in the absorption of sulfisoxazole from the rat rectum and 
pointed out the resemblance of this work to those of Nissim and Taylor. 
Aoki et al. (U) studied the effects of stirface active agents (ionic 
and non-ionic) on intestinal absorption of drugs using three methods, 
(a) circulation of the drug "with surfactant, (b) perfusion vrLth sur­
factant solution followed by perfusion of drug solution free from 
surfactant, and (c) feeding experiments of siirfactant solutions, fol-
lovred by circulation of drug solution. It was found that due to the 
solubilizing action and degeneration of the surfactants on the mucus 
membrane, the absorption of ionized species was decreased more compared 
to its normal absorption, but the absorption of un-ionized species of 
the drug was not decreased in the presence of surfactants, rather it 
was increased. The other effect observed was decreased absorption of 
drugs due to coirrolexation with surfactants (non-ionics had least action 
in this respect). Nadai et al. (113) found that sodium lauryl sulfate 
produced pronotinced changes in the gross appearance of the mucosal 
surface of the small intestine of the rat and thj.3 is invariably ac­
companied by the increased changes in permeability. Morphological 
changes were associated conceivably with the solubilization of the 
lipid cciT^Jonents of the membrane such as lipoproteins. 
CHAPTER III 
OBJECTIVES OF RESEARCH 
In spite of the fact that DSS and polaxalene are used widely 
in medicine as fecal softeners very few reports are available of their 
effects on absorption of drags. The ptirpose of this study was to find 
the effects of DSS and polaxalene on the absorption of a poorly ab­
sorbed drug (phenol red) and a poorly soluble drug (s\ilfisoxazole). 
Although Lish (96) has studied the effects of DSS and polaxalene on 
the absorption of phenol red, his study was limited to only rat colons 
and only to one concentration of the surfactants. Since the action of 
STirfactants on the absorption of drugs is known to be concentration 
dependent and since phenol red, like most other dmgs, is absorbed 
mainly from the upper gastrointestinal tract, a more detailed study of 
the effects of DSS end polaxalene on the absorption of phenol red and 
stilfisoxazole was deemed necessary. 
The objectives of this study are the following: 
(1) Determination of the effects of the surfactants on the 
absorption of phenol red and sulfisoxazole from intact 
rat, 
(2) Determination of the effects of the surfactants on the 
absorption of phenol red from rat small intestinal loops. 
(3) Determination of the effects of DSS on the absorption of 
phenol red from peritoneal cavity of the rat. 
CHAPTER IV 
EXPERIMENTAL 
Materials 
The following materials were used in these experiments: 
Phenolsulfonphthalein (phenol red) 
J. T. Baker, Analytical Grade 
Dioctyl Sodium Sulfosuccinate (DDS) 
E. H. Sargent and Conpany 
Polaxalene, "Polyoxyethylene polyoxypropyline polymer" 
(Pluronic F-68) 
T^andote Chemicals, Vfyandote, Michigan 
Sulfisoxazole (U.S.P.) 
Hoffman LaRoche, New Jersey 
Octanol-1 (n-Octanol) 
J. T. Baker, Analytical Grade 
Procedures 
Influence of DSS and Polaxalene on 
the Gastrointestinal Absorpti^ 
of Phenol Red 
Intestinal loop. Male Sprague Dawley rats, weighing between 
195 and 330 grams, were starved for 18-20 hours with water allowed ad 
libitum. The rats were anesthetized with ether and a midline incision 
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was made to expose the abdominal cavity. A small incision was made in 
the small intestine about 0.5-1 cm from the pyloric end and a hypo­
dermic needle (22 gauge) with a blunt end was inserted into the inci­
sion and secured tightly with a silk suture. Another small incision 
was made in the small intestine about 0.5-1 cm from the ileo-cecal 
junction and this portion of the small intestine was kept outside the 
abdominal cavity. About 3 ml of normal saline was placed in the peri­
toneal cavity to hydrate the intestine. Nomal saline (50 ml) was 
pushed slowly through the small intestine \jntil the washings became 
clear of the particulate matter. The rats were kept under anesthesia 
for 20-25 minutes, before closing the ileo-cecal end, to allow for 
absorption of any residual liq\aid. 
Exactly 5 ml of phenol red solution (0.75 mg/ml) in distilled 
water or in various concentrations of the surfactant solution was in­
jected into the intestinal loop from the pyloric end. The needle was 
then taken out, making sure that no solution came out and the suture 
was tightly secured at the same time. The abdominal cavity was closed 
with sutTires and the animal was left for 3 hoiu's. During this time 
the animal had recovered from anesthesia and was kept in a cage. The 
animal was sacrificed after the 3-hour period; the whole small intes­
tine was removed and washed with normal saline to get rid of any blood 
on its surface. Then it was homogenized in a Waring blender with a 
little water (96) and transferred to a 500 ml volumetric flask. To 
this was added the calculated volume of 9$% ethanol needed to make the 
final solution 10% in ethanol content. The blender was rinsed with 
distilled water and the washings were added to the volximetric flask 
Sh 
and then the voltune was made up to 500 ml with distilled water. The 
solution was left for 30 minutes to allow for precipitation of pro­
teins. Then about 3^ nil of this solution was centrifuged at 7,000 
r.p.m. for 20 minutes. Then 25 ml of the clear supernatant solution 
was pippetted out and transferred to a ̂ 0 ml volumetrtc flask. Then 
1 ml of 2N NaOH was added and the volume was made up to 50 ml with 70% 
ethanol. 
The absoi^ance of this solution was measured at 560 m>i against 
70% ethanol in a Bausch & Lomb Spectronic 600 spectrophotometer. 
The percent of phenol red absorbed was calculated by measroring 
the difference in absorbancy between the original solution diluted in 
the same manner (5 ml to 1,000 ml) and the intestinal homogenate 
solution. 
This method for calculating the percent absorption of phenol 
red runs a higher risk of experimental error compared to a direct 
measurement. However, extreme care was taken in introducing the same 
volume of drug solution into the intestinal loop each time. Furthermore, 
the study deals with the differences between phenol red solution and 
phenol red solutions containing surfactants, so that any experimental 
error due to the techniques was expected to be constant. 
Gastric intubation. Male Sprague Dawley rats -weighing between 
195 and 300 grams were starved for 18-20 hours, with water allowed ad 
libit\3m. The experiments were performed in a cross over fashion, i.e., 
each rat serving as its own control. 
Each rat received a control dose of 2 ml of phenol red solution 
in distilled water (0.75 mg/ml) by gasti*ic intubation (by means of a 
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Tygon tube). The animal was then kept in a metabolic cage, and water 
was allowed ad libitum, but food was withheld. The urine was collected 
for a period of 2h ho\irs. 
After a recovery period of three days, the same rat received 
2 ml of phenol red solution (0.75 mg/ml) in one of the different con­
centrations of the surfactants studied. The urine was collected for a 
period of 2h hours as mentioned before. 
Half the number of animals first received control doses of the 
drug, followed by a dose of the dr\ig with the surfactant after the re­
covery period. While in the other half nioniber of animals, the procedure 
was reversed, i.e., first a dose of the drtig was given with the surfac­
tant followed by a control dose of the drug after the recovery period. 
The pH of the urine was adjusted to 10.00 vjith 2N sodium 
hydroxide solution and the volume of the sanple was made up to 50 ml. 
A portion of the sanple was filtered through Millipore filter (O.U5 
and its phenol red content was determined by measuring its absorbance 
against a blank prepared in the same manner as the sample, at 560 mja 
in a spectrophotometer (38)* 
Using a standard curve for phenol red, the percent of the dose 
absorbed by the rat was calculated. 
Influence of DSS on the PeirLtoneal 
Absorption of Phenol Red 
Male Sprague Dawley rats weighing between 210 and 380 grams 
were starved for 18-20 hours with water allowed ad libitum. The exper­
iments were performed in a cross over fashion, i.e., each rat serving 
as its own control. 
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Each rat received a control dose of 0.5 ml of phenol red solu­
tion in distilled water (0.75 mg/ml) by intraperitoneal injection. The 
animal was kept in a met^olic cage, and water was allowed ad libitum 
but food was withheld. The tirine was collected for a period of 2U 
hours. After a recovery period of three days the same rat received a 
dose of 0.5 ml of phenol red solution (0.75 mg/ml) in one of the dif­
ferent concentrations of DSS in distilled water. The urine was again 
collected for a period of 2h hours as mentioned before. 
The content of phenol red in the urine was determined as 
described previously mder "Gastric intubation", but the voliime of 
urine was made up to 100 ml. 
Effect of DSS and Polaxalene on the 
Equilibritun Solubility of "Phenol 
Red at 37^0. 
Excess amounts of phenol red powder were placed in 25 ml anpules 
and then 10 ml of various solutions of the STirfactants were added to 
the an5)ules. The arapxiles were sealed and rotated in a Metabolyte shaker 
maintained at 37®C. After equilibrium was achieved (approximately 3 
days), an aliquot was filtered through a Millipore filter (O.U5 >i). 
One ml of this filtered solution was diluted to 500 ml after adding 
2N sodixim hydroxide to adjust pH to 10.0. The absorbance of this solu­
tion was measured at 560 mu in a spectrophotometer. 
Effect of DSS on the Apparent Partition 
Coefficient of Phenol Red betvreen 
Octanol-1 and Surfactant Solution 
Solutions of phenol red (0.05^) were prepared in phosphate 
buffer^ (M/IOO and pH 6.0) or in the same biiffer containing various 
Iciark and Lubs Phosphate Buffer. 
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concentrations of DSS. Ten ml of buffered phenol red solution was 
added to an equal volume of octanol-1, previously saturated with the 
buffer solution, in a ^0 ml Erlenmeyer flask. The contents were equil­
ibrated at 37°C for two days. After separation by centrifugation (at 
11,000 r.p.m., for 30 minutes, and at 37°C) an aliquot (l ml) of the 
aqueous phase was rendered alkaline (pH 10.0) with sodium hydroxide 
solution and diluted to 2^0 ml with distilled water. The absorbancy 
of this solution was measured at 560 and the apparent partition 
coefficient was calculated from the decrease JLn the concentration of 
phenol red in the aqueous phase. 
Influence of DSS on the Gastrointestinal 
Absorption of Sulfisoxazole 
Gastric intubation. Male Sprague Dawley rats weighing between 
200 and 2U0 grams were starved for 18-20 hours, with water allowed ad 
libitum. The experiments were performed in a cross over fashion, i.e., 
each rat serving as its own control. 
Each rat received a control dose of 5 mg of sulfisoxazole in 
the form of a suspension in distilled water. Preparation of a drug 
suspension was done in situ by placing the drug into the barrel of a 
dry 5 ml syiringe, adding 2 ml water to it and intubating the resulting 
suspension. An additional 1.5 ml of water was added in small increments 
to ensure conplete delivery of the drug from the syringe. The animal 
was then kept in a metabolic cage, water was allowed ad libitum but 
food was withheld. The urine was collected for a period of 2U hours. 
After a recovery period of three days the same rat received 
the same amount of the dmg suspended in 2 ml of one of the various 
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concentrations of the DSS solution. A 1.^ ml of water was added in 
small increments to the syringe to ensure complete delivery of the 
drug. The urine was collected for a period of 2h hours as mentioned 
before. 
Half the number of animals first received control dose followed 
"by a dose of the drug with the surfactant after the recovery period. 
I-Jhile in the other half nrmiber of animals, the procedvire was reversed, 
i.e., first a dose of the drug was given with the surfactant, followed 
by a control dose of the drtig after the recovery period. 
UirLnary analysis for sulfisoxazole. The total urinary excre­
tion of the sulfisoxazole (free, as well as acetylated portion) by the 
modified Bratton and Marshal method (30). 
Urine was diluted to exactly 100 ml and a 10 ml aliquot was 
pippetted out in a 100 ml volumetric flask, to which was added 10 ml 
of 0.^ N hydrochloric acid. This mixture was heated on a steam bath 
for one hour to hydrolyze the acetyl ated portion of the excreted drug. 
After cooling, 10 ml of a 0.1^ solution of sodlTom nitrite, freshly pre­
pared, was added and shaken thoroughly. After 6 minutes, 10 ml of a 
0.5^ solution of ammonium sulfamate was added and shaken thoroughly. 
The pH of the resulting solution was checked and adjusted to a value 
of approximately 1.3-l.U with 1 N hydrochloric acid. Six minutes 
after the addition of ammonium sulfamate, 10 ml of a 0.1^ solution of 
N-l-Naphthylethylenediamine dihydrochloride was added. The voltune was 
adjusted to 100 ml and a portion of it was filtered through a KLllipore 
filter (O.li^ u). The absorbance of this solution was read at 533 
against a blank prepared in the same manner. 
^9 
The amount of sulfisoxazole absorbed was calcxilated by means 
of a standard cujrve. 
Effect of DSS on the Solubility of 
Sulfisoxazole at Room Temperature 
Sulfisoxazole (lOO mg) was placed in a 20 ml test tube and 
5 ml of various concentrations of DSS solutions, prepared in M/5 
phosphate buffer, were added to it. The tube was shaken at a medium 
speed on a vortex mixer for exactly 5 minutes at room temperature. It 
was then filtered through a Millipore filter (o.U5 >i). One ml of this 
filtered solution was properly diluted with a phosphate buffer of pH 
7.5 Absorbance of this solution was read against a blank 
(phosphate buffer) at 2^2 mji. 
Statistical Analysis of Res\alts 
To find out the significance of the effect of various concen­
trations of surfactants a student t test for the significant difference 
in the means was performed. An analysis of variance in conjunction 
with an F test was also performed. This analysis involves an extension 
of the pooled variance technique and the calctilation of a variance 
ratio. This is in contrast to the ratio of the difference between 
means to the standard error of the difference required by the t test. 
This analysis answers the same question as a student t test does for 
the difference between two means and is used as a test of significance 
for two or more groups of data. 
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Table 1 
Influence of DSS on the Gastrointestinal Absorption 
of Phenol Red - Intestinal Loop 
Phenol Red 
Rat 
Absort>ance at $60 irqa 
Phenol Red 
Solution 
Intestinal 
Homogen ate 
Percent Dose 
Absorbed 
1 
2 
3 
h 
6 
0.668 
0.668 
0.563 
0.563 
0.563 
0.573 
0.6U0 
0.635 
0.5U0 
0.5U0 
0.537 
0.5U5 
U.19 
U.9U 
U.08 
U.08 
U.62 
U.89 
Arithmetic 
Mean 
Standard 
Devi ation 
Standard 
Error 
0.5996 0.5728 
0.0502 
0.0205 
U.U667 
0.U006 
0.1635 
61 
Table 2 
Influence of DSS on the Gastrointestinal Absorption 
of Phenol Red - Intestinal Loop 
Phenol Red + 0,2^% DSS (12.5 nig) 
Absorbance at 560 it^i 
Percent Dose 
Absorbed 
Rat Phenol Red Intestinal 
Solution Homogenste 
1 0.595 0.505 6.72 
2 0.595 0Ji70 21.00 
3 0.595 0.500 16.00 
U 0.595 0.h75 20.17 
5 0.595 0.U60 22.67 
6 0.595 O.U85 18.50 
Arithme ti c Ke an 0.U825 17.5100 
Standard Deviation 0.0175 5.75UU 
Standard Error 0.0071 2.3500 
t = 5.5387 (significant difference at p < .001 when compared to control) 
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Table 3 
Influence of DSS on the Gastrointestinc*! Absorption 
of Phenol Red - Intestinal Loop 
Phenol Red + DSS (2^ mg) 
Absorbance at 560 mvi 
Percent Dose 
Rat Pheno]. Red 
Solution 
Intestinal 
Homo gen ate 
Absorbed 
1 0.^90 0.390 33.88 
2 0.^90 0.380 35.59 
3 0.590 0.360 38,98 
U 0.590 O.3I4O )p. ̂7 
5 0.590 0.185 68.6U 
6 0.590 0.160 72.68 
7 0.590 0.130 77.96 
6 0.590 0.120 79.66 
9 0.590 0.380 35.59 
Arithmetic Mean 0.2717 53.9278 
Standard Devi ation 0.1188 20.1223 
Standard Error 0.0396 6.707U 
t = 5.9UUU (significant difference at p< .001 when copqjared to control) 
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Tdjle U 
Influence of DSS on the Gastrointestinal Absoiption 
of Phenol Red - Intestinal Loop 
Phenol Red + 1.0^ DSS (50.0 mg) 
Rat 
Absorbance at 560 npa 
Percent Dose 
Absorbed Phenol Red 
Solution 
Intestinal 
Homogen ate 
1 0.600 0.353 U1.177 
2 0.600 O.IUO 76.67 
3 0.600 O.lhO 76.67 
li 0.600 0.115 80.83 
0.600 0.108 82.00 
6 0.600 0.095 8ii.l7 
Arithmetic Mean 0.1^8^ 73.58U5 
Standard Deviation 0.0969 16.157U 
Standard Error 0.0396 6,6000 
t = 10.U76 (significant difference at p <.001 when compared to control) 
6h 
Table ^ 
Influence of I)SS on "the Gastrointestinal Absorption 
of Phenol Fed - Intestinal Loop 
Phenol Red + 1,^% DSS (7^.0 mg) 
Absorb ance at 560 m|i 
Percent Dose 
Rat 
Phenol Red 
Solution 
Intestinal 
Homogen ate 
Absorbed 
1 0.^90 0.380 35.59 
2 0.590 0.3U0 U2.37 
3 0.590 0.305 U8.3O 
U 0.590 0.265 55.08 
0.590 0.270 5U.2U 
6 0.590 0.185 68.6U 
Arithmetic Mean 0.2908 50.7033 
Standard Deviation 0.0676 II.I1632 
Standard Eri*or 0.0276 U.6807 
t = 9.8739 (significant difference at p < .001 when compared to control) 
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Table 6 
Influence of DSS on the Gastrointestinal Absorption 
of Phenol Red 
Total Urinary Excretion of Phenol Red in Individual 
Rats after Gastric Intubation of Phenol Red (1.5 mg 
dose) with and -without 0.5^ DSS (10 mg). 
Control DSS 
Rat Absorbance 
at 560 m^ 
Percent Dose 
Absorbed 
Absorbance 
at 560 in)i 
Percent Dose 
Absorbed 
1 0.260 5.U2O 0.365 7.609 
2 0.290 6.0U5 o.iao 8.5U7 
3 0.210 U.378 0.350 7.296 
h 0.280 5.837 0.U70 9.798 
5 0.216 U.503 0.360 7.505 
6 0.220 U.586 0.382 7.963 
7 0.230 U.795 O.UOO 8.338 
8 0.190 3.961 O.U3O 8.96U 
9 0.200 U.169 O.U65 9.693 
Arithmetic 
Mean 0.2329 U.85U8 0.U036 8.U125 
Standard 
Deviation 0.0356 0.7U13 0.0UU2 0.9223 
Standard 
Error 0.0118 0.2U71 0.01U7 0.307U 
t = 9.6IU7 (significant difference at p < .001) 
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T^le 7 
Influence of DSS on the Gastrointestinal Absorption 
of Phenol Red 
Total Urinary Excretion of Phenol Red in Individual 
Rats after Gastric Intubation of Phenol Red (1.5 mg 
dose) with and vdthout 1.0^ DSS (20 mg). 
Control DSS 
Rat Absorb ance 
at 560 in)i 
Percent Dose 
Absorbed 
Absorb ance 
at 560 
PercentDose 
Absorbed 
1 O.3UO 7.088 O.U8O 10.006 
2 0.210 U.378 0.310 6.U62 
3 0.270 5.628 O.UlU 8.630 
u 0.310 6.U62 0.530 11.0U9 
0.212 U.U19 0.580 12.091 
6 0.217 U.52U 0.580 12.091 
7 0.300 6.25U O.7UO 15.U26 
8 0.261 5.uia O.7UO I5.U26 
9 0.210 U.378 0.U3U 9.0U7 
Arithmetic 
Mean 0.2589 5.3969 0.53U2 II.I36U 
Standard 
Deviation 0.0U97 1.0355 o.iua3 3.0085 
Standard 
Error 0.0165 0.3U52 O.OU8I 1.0028 
t = 5.8987 (significant difference at p < .001) 
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Table 8 
Influence of DSS on the Gastrointestinal Absorption 
of Phenol Red 
Total Ui*inary Excretion of Phenol Red in Individual 
Rats after Gastric Intubation of Phenol Red (1.5 mg 
dose) with and without 1.5^ DSS (30 mg). 
Control DSS 
Rat Absorb ance 
at 560 inji 
Percent Dose 
Absorbed 
Absorbance 
at 560 
Percent Dose 
Absorbed 
1 0.230 U.795 0.388 8.088 
2 0.2UU 5.086 0.500 10.U23 
3 0.238 li.96l O.U95 10.319 
h 0.2U7 5.1U9 0.558 11.632 
5 0.20h U.253 0.ii80 10.006 
6 0.220 U.586 0.605 12.612 
7 0.190 3.961 0.500 IO.U23 
8 0.190 3.961 0.565 11.778 
9 0.190 3.961 0.690 lii.38U 
Arithmetic 
Mean 0.2170 U.5237 0.^312 11.0739 
Standard 
De^rLation 0.02U0 0.h999 0.0858 1.7889 
Standard 
Error 0.0079 0.1666 0.0186 0.5963 
t = 9.68^9 (significant difference at p <.001) 
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Table 9 
Influence of DSS on the Gastrointestinal Absorption 
of Phenol Red 
Total Urinary Excretion of Phenol Red in Individual 
Rats after Gastric Intubation of Phenol Red (l.^ mg 
dose) with and without 2»0% DSS (UO mg). 
Control DSS 
Rat Absorbance 
at 560 mji 
Percent Dose 
Absorbed 
Absorbance 
at 560 
Percent Dose 
Absorbed 
1 0.2U5 5.107 0.351 7.317 
2 0.215 U.U82 0.385 8.026 
3 0.195 U.065 0.365 7.609 
U 0.165 3.UU0 0.325 6.775 
0.190 3.961 0.362 7.5U6 
6 0.195 U.065 o.Uoo 8.338 
7 0.135 2.81U 0.300 6.251; 
8 0.210 U.378 0.U90 10.215 
9 0.2U0 5.003 0.560 11.673 
Arithmetic 
Mean 0.1978 U.IU6I 0.3931 8.19U8 
Standard 
Deviation 0.0350 0.7198 0.0823 1.7156 
Standard 
Error 0.0115 0.2399 O.O27U O.57I8 
t = 8.8382 (significant difference at p < .001) 
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Table 10 
Influence of DSS on the Peritoneal Absorption 
of Phenol Red 
Total Urinary Excretion of Phenol Red in Individual Rats 
after Intraperitoneal Administration of 0.37^ mg dose of 
Phenol Red with and without 0.01^ DSS (O.O^ mg). 
Control DSS 
Rat Absorbance 
at 560 
Percent Dose 
Absorbed 
Absorbance 
at 560 rrgi 
Percent Dose 
Absorbed 
1 O.3UO $6,102 o.iao 68.376 
2 0.315 53.533 0.380 63.373 
3 O.U05 67.5U2 O.U35 72.5U5 
U 0.3U5 57.536 O.UI5 69.210 
5 O.U05 67.5U2 0.U22 70.377 
Arithmetic 
Mean 0.3620 60.3711 0.U12U 68.7763 
Standard 
Deviation 0.0U09 6.8152 0.020U 3.U026 
Standard 
Error 0.0182 3.0U79 0.0091 1.5217 
t = U.U96O (significant difference at p ^ .02) 
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TdDle 11 
Inriuence of DSS on the Peritoneal Absorption 
of Phenol Red 
Total Urinary Excretion of Phenol Red in Individual Rats 
after Intr^eirLtoneal Administration of 0.37^ mg dose of 
Phenol Red with and without 0.0^/S DSS (0.2^ ing). 
Control DSS 
Rat Absorbance 
at 560 rnji 
Percent Dose 
Absorbed 
Absorbance 
at 560 iT^ 
Percent Dose 
Absorbed 
1 0.332 55.368 0.390 65. Ola 
2 O.2i1o U0.025 0.320 53.367 
3 0.320 53.367 0.370 61.705 
U 0.3^5 59.20U 0.385 6u.207 
0.30^ 50.8651 0.360 60.037 
Arithmetic 
Mean 
Standard 
Deviation 
Standard 
O.3IOU 
0.0U3U 
51.7657 
7.2373 
0.365 
0.0278 
6o.87iu 
U.6U27 
Error 0.019U 3*236? 0.012U. 2.0763 
t = 6.816U (significant difference at p < .00^) 
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T^le 12 
Influence of DSS on the Peritoneal Absorption 
of Phenol Red 
Total Urinary Excretion of Phenol Red in Individual Rats 
after Intrsperitoneal Administration of 0.37> mg dose of 
Phenol Red with and without 0.10^ DSS (0.50 mg). 
Control DSS 
Rat Absorbance 
at ^60 iryi 
Percent Dose 
Absorbed 
Absorb ance 
at 560 m)i 
Percent Dose 
Absorbed 
1 0.310 51.699 0.350 53.370 
2 0.29^ U9.197 0.320 53.367 
3 0.325 5U.200 0.358 59.70U 
U 0.260 U3.360 0.310 51.699 
0.320 53.366 0.330 55.O3U 
Arithmetic 
Mean 0.3020 50.36u8 0.3336 55.63U8 
Standard 
Deviation 0.0261 U.3569 0.0201 3.355U 
Standard 
Error 0.0117 1.9U85 0.0090 1.5006 
t = U.6^60 (significant difference at p <.01) 
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Table 13 
Influence of DSS on the Peritoneal Absorption 
of Phenol Red 
Total Urinary Excretion of Phenol Red in Individual Rats 
after Intrsperitoneal Administration of 0.375 ng dose of 
Phenol Red with and without 0.50^ DSS (2.50 mg). 
Control DSS 
Rat Absorbance 
at 560 mji 
Percent Dose 
Absorbed 
Absorb ance 
at 560 npi 
Percent Dose 
Absorbed 
1 0.300 50.031 0.250 Ul.693 
2 0.280 U6.696 0.237 39.525 
3 0.2U3 U0.525 0.165 27.517 
U 0.290 u8.36u O.2I43 UO.525 
5 0.355 59.2037 0.310 51.699 
Arithmetic 
Mean 0.2936 u8.9639 o.2mo UO.i9i8 
Standard 
Deviation 0.0U05 6.758U 0.0516 8.6oou 
Standard 
Error 0.0181 3.0225 0.0231 3.8u63 
t = 8.1u9u (significant difference at p < .005) 
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Table lU 
Influence of DSS on the Peritoneal Absorption 
of Phenol Red 
Total Urinary Excretion of Phenol Red in Individual Rats 
after Intr^eritoneal Administration of 0.37^ mg dose of 
Phenol Red with and without 1.00^ DSS (5.00 mg). 
Control DSS 
Rat Absorbance 
at 560 11^ 
Percent Dose 
Absorbed 
Absorb ance 
at 560 rrgi 
Percent Dose 
Absorbed 
1 0.370 61,705 0.210 35.022 
2 0.310 51.699 0.200 33.35U 
3 0.320 53.367 0.175 29.185 
h 0.320 53.367 0.195 32.520 
0.360 60.037 0.280 U6.695 
Arithmetic 
Mean 0.3360 56.0350 0.2120 35.355U 
Standard 
Deviation 0.0272 U.5058 O.OUOl 6.6865 
Standard 
Error 0.0122 2.0151 0.0179 2.990U 
t = 8.9im (significant difference at p < .001) 
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Table 15 
]jifl-uence of DSS on the Peritoneal Absorption 
of Phenol Red 
Total Urinary Excretion of Phenol Red in Individual Rats 
after Intraperitoneal Adinini strati on of 0.3715 mg dose of 
Phenol Red with and without 1.^0^ DSS (7.5 nig). 
Control DSS 
Rat Absorb ance 
at 560 mji 
Percent Dose 
Absorbed 
Absorb ance 
at 560 
Percent Dose 
Absorbed 
1 0.293 U8.86U 0.12U 20.680 
2 0.350 58.370 0.160 26.683 
3 0.3U0 56.702 0.170 28.351 
U 0.367 61.205 0.218 36.356 
5 0.360 60.037 0.200 33.35U 
Arithmetic 
Mean 0.3U20 57.0356 0.17UU 29.08U8 
Standard 
Deviation 0.0292 U.8750 0.0365 6.0838 
Standard 
Error 0.0130 2.1802 0.0163 2.7208 
t " 2U,8031 (significant difference at p A
 • o
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Table l6 
Influence of Polaxalene on the Gasti\5intestinal Absorption 
of Phenol Red - Intestinal Loops 
Phenol Red 
Absorbance at 560 
Rat Phenol Red 
Solution 
Intestinal 
Homogenate 
Percent Dose 
Absorbed 
1 0.668 0.6U0 U.19 
2 0.668 0.635 U.9U 
3 0.563 0.5U0 U.08 
h 0.563 0.5U0 U.08 
5 0.563 0.537 U.62 
6 0.573 0.5U5 U.89 
Arithmetic 
Mean 0.5996 0.5728 U.u667 
Standard 
Devi ation 0.0502 0.)4006 
Standard 
Error 0.0205 0.1635 
I 
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Table 1? 
Influence of Polaxalene on the Gastrointestinal Absorption 
of Phenol Red - Intestinal Loops 
Phenol Red + \% Polaxalene (^0 mg) 
Absorbance at 560 mji 
Rat Phenol Red 
Solution 
Intestinal 
Homogenate 
Percent Dose 
Absorbed 
1 0.^75 0.5U7 U.87 
2 0.57^ 0.555 3.U8 
3 0.^7^ 0.560 2.68 
U 0.57^ 0.552 U.OO 
5 0.575 0.550 U.35 
6 0.575 0.551 U.17 
Arithmetic Mean 0.5525 3.9250 
Standard Deviation 0.00U5 0.7599 
Standard Error 0.0018 0.3102 
t « 1.5UU5 (no significant difference when coirpared to control) 
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Table 18 
Influence of Polaxalene on the Gastrointestinal Absorption 
of Phenol Red - Intestinal Loops 
Phenol Red + 2% Polaxalene (100 mg) 
Absorbance at 560 up 
Rat Phenol Pied 
Solution 
Intestinal 
Homogenate 
Percent Dose 
Absorbed 
1 0.570 0.5U0 5.26 
2 0.570 0.5U0 5.26 
3 0.570 0.550 3.51 
\x 0.570 0.5Li7 U.03 
$ 0.570 0.550 3.51 
6 0.570 0.555 2.70 
Arithmetic Mean 0.5U7 U.0U5 
Standard Deviation 0.006 1.0329 
Standard Error 0.002U 0.U217 
t = 0.9323 (no significant difference when conpared to contixjl) 
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Table 19 
Influence of Polaxalene on the Gastrointestinal Absorption 
of Phenol Red - Intestinal Loops 
Phenol Red + 3^ Polaxalene (l^O mg) 
Absorbance at 560 mji 
Rat Phenol Red 
Solution 
Intestinal 
Homo gen ate 
Percent Dose 
Absorbed 
1 0.^90 0.580 1.69 
2 0.590 0.580 1.69 
3 0.^90 0.580 1.69 
h 0.590 0.585 0.85 
5 0.590 0.585 0.85 
6 0.590 0.575 3.36 
Arithmetic Mean 0.5808 1.U3U8 
Standard Deviation 0.0038 1.1066 
Standard Error 0.0015 O.U518 
t = 6.8038 (significant difference at p <.001 when compared to control) 
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Table 20 
Influence of Polaxalene on the Gastrointestinal Absorption 
of Phenol Red - Intestinal Loops 
Phenol Red + Polaxalene (2^0 mg) 
Absorbance at 560 nyi 
Rat Phenol Red 
Solution 
Intestinal 
Homo gen ate 
Percent Dose 
Absorbed 
1 0.^90 0.585 0.85 
2 0.^90 0.585 0.85 
3 0.^90 0.585 0.85 
U 0.590 0.570 3.39 
0.^90 0.565 U.2)4 
6 0.590 O.U65 U.2U 
Arithmetic Mean 0.5758 2.U023 
Standard Deviation 0.0102 1.728U 
Standard Error 0.00U2 0.7057 
t = 2.8U66 (significant difference at p <.01 when compared to control) 
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Table 21 
Influence of Polaxalene on the Gastrointestinal Absorption 
of Phenol Red 
Total Urinary Excretion of Phenol Red in Individual Rats 
after Gastric Intubation of Phenol Red (l.^ itig dose) with 
and without 0.^% Polaxalene (10 mg). 
Control Polaxalene 
Rat Absorbance 
at $60 ngi 
Percent Dose 
Absorbed 
Absorb ance 
at 560 rr^i 
Percent Dose 
Absorbed 
1 O.lUO 2.918 0.250 5.212 
2 0.295 6.150 0.330 6.879 
3 0.260 5.U20 0.200 U.169 
U 0.320 6.671 0.220 U.586 
5 0.3U0 7.088 0.3U0 7.088 
Arithmetic 
Mean 0.2710 5.6U9U 0.2680 5.5868 
Standard 
Deviation 0.0791 1.6U87 0.0638 1.3299 
Standard 
Error 0.035U 0.7373 0.0285 0.59U8 
t = 0.0818 (no significant difference) 
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Table 22 
Influence of Polaxalene on the Gastrointestinal Absorption 
of Phenol Red 
Total Urinary Excretion of Phenol Red in Individual Rats 
after Gastric Intubation of Phenol Red (1.5 mg dose) 
with and without 1,^% Polaxalene (30 mg). 
Control Polaxalene 
Rat Absorb ance 
at 560 Tn)i 
Percent Dose 
Absorbed 
Absorb ance 
at 560 rnji 
Percent Dose 
Absorbed 
1 0.220 U.586 0.200 u.i69 
2 0.260 5.U20 0.160 3.335 
3 0.2U0 5.003 0.2U0 5.003 
U o.iuo 2.918 0.200 a.169 
0.22U U.670 0.270 5.628 
6 0.170 3.5hU 0.180 3.752 
7 0.2^6 5.337 0.200 u.i69 
Arithmetic 
Mean 0.2157 U.U968 0.2071 U.3I82 
Standard 
Devi ation 0.UU9 0.9355 0.0368 0.7680 
Standard 
Error 0.0170 0.3536 0.0139 0.2903 
t = o.uou? (no significant difference) 
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Table 23 
Influence of Polaxalene on the Gastrointestinal Absorption 
of Phenol Red 
Total Urinary Excretion of Phenol Red in Individual Rats 
after Gastric ]jnitubation of Phenol Red (1.5 mg dose) 
with and without 2.^% Polaxalene (50 mg). 
Control Polaxalene 
Rat Absorbance 
at 560 
Percent Dose 
Absorbed 
Absorb ance 
at 560 rga 
Percent Dose 
Absorbed 
1 0.260 5.U20 0.220 U.586 
2 0.170 3.5UU 0.280 5.837 
3 0.310 6.U62 0.250 5.212 
U 0.310 6.U62 0.220 U.586 
5 0.280 5.837 0.270 5.628 
6 0.200 U.169 0.286 5.962 
Arithmetic 
Mean 0.2^^0 5.3159 0.25U3 5.3015 
Standard 
Devi ation 0.0582 1.2138 0.0293 0.6097 
Standard 
Error 0.220 O.U588 0.0111 0.230u 
t = 0.0201 (no significant difference) 
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Table 2h 
Influence of Polaxalene on the Gastrointestinal Absorption 
of Phenol Red 
Total Urinary Excretion of Phenol Red in Individual Rats 
after Gastric Intubation of Phenol Red (1.^ mg dose) 
with and without ^,0% Polaxalene (100 mg). 
Control Polaxalene 
Rat Absorbance Percent Dose Absorbance Percent Dose 
at 560 Tn}i Absorbed at $6o nqi Absorbed 
1 0.280 5.837 0.170 3.51^11 
2 0.260 5.U20 0.230 U.795 
3 0.180 3.752 0.100 2.085 
U 0.190 3.961 0.200 U.169 
5 0.290 6.0li5 0.180 3.752 
Arithmetic 
Mean O.2uoo 5.0031 O.i76o 3-6690 
Standard 
Deviation 0.0^1^ 1.0731 O.ou83 I.oo63 
Standard 
Error 0.0230 O.U799 0.0216 O.U^OO 
t « 2.71h2 (significant difference at p < .05) 
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Table 2$ 
Effect of DSS on the Apparent Partition Coefficient of 
Phenol Red between Octanol-1 and S\irfactant Solution 
Absorbance of Aqueous Phase Apparent Partition 
Concentration at 560 mu Coefficient 
of DSS ^ Af+.F>T* Octanol—1/DSS Solution 
Partitioning^ Partitioning^ 
0. 0.325 0.297 0.086 
0.01 0.319 O.29I1 0.078 
0.10 0.320 0.296 0.075 
0.25 0.329 0.305 0.073 
0.50 0.319 0.295 0.075 
1.00 0.320 0.298 0.069 
1.50 0.332 0.306 0.078 
^Average of two sanples. 
^Average of three senples. 
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Table 26 
Effect of Polaxalene on the Eqtiilibriuin Solubility 
of Phenol Red at 37° C 
Concentration of 
Polaxalene (Percent) 
Absorbance at 
560 
Solvibility of Phenol 
Red (gm/litre)^ 
0 0.370 1.1^6 
0."^ 0.378 1.181 
1.0 O.U37 1.366 
2.0 0.UU8 i.Uoo 
3.0 O.U86 1.^19 
U.o 0.U9U l.^hU 
.̂0 0.^00 1.563 
^Average absorbancies of six samples. 
^Calculated by the following equation: 
Absorbancy = e x concentration (mg/litre) 
e = 0.l6, as determined by the method of least squares 
from the standard curve. 
Factor of dilution: 1 to ^00 ml. 
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Table 27 
Effect of DSS on the Equilibrium Solubility 
of Phenol Red at 37° C 
Concentration of 
DSS (Percent) 
Absorbance at 
560 mp®-
Solubility of Phenol 
Red (gm/litre)^ 
0 0.370 1.156 
0.25 0.U2U 1.325 
0.50 0.U80 1.500 
0.75 0.515 1.609 
1.00 0.558 1.7UU 
1.25 0.578 1.806 
1.50 0.590 l.SlUi 
2.00 0.639 2.166 
^Average absorbancies of six samples. 
^Calculated by the following equation: 
Absorbance = e x concentration (mg/litre) 
e = 0.16, as determined by the method of least squares 
from the standard ciirve. 
Factor of dilution: 1 to ^00 ml. 
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Table 28 
Influence of DSS on the Gastrointestinal Absorption 
of Sulfisoxazole 
Total Urinary Excretion of Sulfisoxazole in Individual 
Rats after Gastric Intubation of Sulfisoxazole mg) 
with and without 0,1% DSS (2 mg). 
Control DSS 
Rat Absorbance 
at 533 1191 
Dose Absorbed Absorbance 
at 533 iTi)i 
Dose Absorbed 
mg 
1 O.UlO 3.hl7 0.U30 3.583 
2 0.k20 3.500 0.U50 3.750 
3 0.360 3.000 0.382 3.183 
U 0.380 3.167 o.ia5 3.U58 
5 O.U15 3.U58 O.U33 3.608 
6 O.U95 U.125 O.U75 3.958 
7 O.UlO 3.1U7 0.U50 3.750 
8 0.390 3.250 0.u20 3.500 
9 0.)4U0 3.667 O.U55 3.792 
10 0.U20 3.500 0.u80 U.ooo 
Arithmetic 
Mean O.UlU 3.U50 O.U39 3.658 
Standard 
Deviation 0.036 O.30u 0.029 0.2U5 
Standard 
Error 0.011 0.096 0.009 0.078 
t = 3.80U8 (significant difference at p < .00^) 
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Table 29 
Influence of DSS on the Gastrointestinal Absorption 
of Sulfisoxazole 
Total Urinary Excretion of Sulfisoxazole in Individual 
Rats after Gastric Intubation of Stilfisoxazole (5 mg) 
with and i-Tithout 0.^% DSS mg). 
Control DSS 
Rat Absorb ance 
at 533 irai 
Dose Absorbed 
mg 
Absorbance 
at 533 
Dose Absorbed 
mg 
1 0.380 3.167 0.)475 3.958 
2 o.U^o 3.750 O.U65 3.875 
3 0.U85 U.0u2 0.520 a.333 
U o.U?o 3.750 0.U80 U.ooo 
5 0.U90 U.083 0.560 U .667 
6 0.305 3.208 0.520 U.333 
7 0.U20 3.500 O.u6o 3.833 
8 0.U50 3.750 0.500 U.167 
9 0.395 3.292 0.510 U.250 
10 o.hio 3.La7 0.520 U.333 
Arithmetic 
Mean 0.U31 3.596 0.501 U.175 
Standard 
Deviation 0.039 0.329 0.031 0.260 
Standard 
Error 0.012 O.lOU 0.010 0.082 
t = 5.27^ (significant difference at p < .001) 
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Table 30 
Influence of DSS on the Gastrointestinal Absorption 
of Sulfisoxazole 
Total Urinary Excretion of Sulfisoxazole in Individual 
Rats after Gastric Intubation of Sulfisoxazole (5 mg) 
with and v/ithout 1.0^ DSS (10 mg). 
Control DSS 
Rat Absorbance Dose Absorbed Absorbance Dose Absorbed 
at 533 iTi)i mg at $33 mg 
1 O.hUO 3.667 0.^70 U.750 
2 0.)430 3.583 0.5U0 U.500 
3 0.380 3.167 0.520 U.333 
h o.Ulo 3.1U7 0.5U0 U.500 
5 0.ij30 3.583 0.570 U.750 
6 0.360 3.000 0.515 U.292 
7 0.U20 3.500 0.585 h.875 
8 0.360 3.000 0.535 U.U58 
9 0.390 3.250 0.530 U.U17 
Arithmetic 
Mean o.UOp 3.380 0.5U5 U.5U2 
Standard 
Devi ation 0.031 0.257 0.02U 0.203 
Standard 
Erixsr 0.010 0.085 0.008 0.067 
t = 21.7398 (significant difference at p < .001) 
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Td5le 31 
Effect of DSS on the Solubility of Sulfisoxazole 
at Room Temperature 
Concentration of Absorb ance 
DSS (Percent) at 2^2 inji 
0.00 0.196^ 
0.01 0.211 
0.0^ 0.211 
0.10 0.212 
^Average of three sanples. 
CHAPTER V 
DISCUSSION 
Phenol red, the drug selected for this study, serves as a good 
model to study the effects of the two medicinally used surfactants, 
dioctyl sodium sulfosuccinate (DSS) and polaxalene, on the absoiption 
of poorly absorbed drugs. 
Phenol red is a weak acid, with a molecular weight of 35U and 
a pKa of 7.9 (106). It is used as an indicator, in acid-base titra­
tions, changing its color in the pH range of 6.0 to 7.^. Using the 
Henderson-Hasselbach equation, one can calculate that the degree of 
ionization of phenol red at <?c pH of 5.3 (the virtual pH at the absorp­
tion site in the intestine) (6l, 1U5) is only 0.2^ percent. However, 
it may generate the strong benzenesulfonic acid group by acid hydrol­
ysis of the sulfalactone ring at very low pH (<2). These suggest 
that the poor absorption of phenol red through small intestine can be 
attributed to low lipid/water partition coefficient of the un-ionized 
form, while the poor absorption through the stomach can be attributed 
to the degree of ionization. This account of the poor absorpability 
of phenol red was suggested by Lien (93), and was confirmed by our 
results, that phenol red has very low partition coefficient (Octanol-
l/water) as shown in Table 25. 
Intestinal perfusion studies in rats have shown that phenol 
red is equally well absorbed in the proximal as well as distal regions 
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of the small intestine (108). In the 0.5 to 20 mg per litre concen­
tration range phenol red absorption from the gastrointestinal tract of 
the rat occurs by passive diffusion (81). At lower concentrations, 
there is appreciable contribution by the specialized transport process, 
which can be inhibited by p-aminohippuric acid (82), 
Influence of DSS on the Absorption of Phenol Red 
Absorption from Intestinal Loops 
The intestinal loop, being a well defined section of the gastro­
intestinal tract of the rat, is well stiited for the study of the absorp­
tion of drugs and the influence of the surfactants on their absorption. 
In this technique, the animal's blood supply remains intact and, hence, 
the absorption profiles obtained are more realistic. In addition, it 
is possible to control the initial concentration of the surfactant 
present within the intestinal lumen, when compared to intact rat. 
The results obtained from the intestinal loops are presented in 
Tables 1 to 5. The percent of phenol red dose absorbed in the control 
studies was about U.^ percent. This value is in good agreement with 
the value of 5.6 percent reported by Feldman et al. (bO). 
The Intestinal loop experiments indicate a dose-dependent 
effect of DSS on the intestinal absorption of the phenol red. The 
relative rate of absorption of phenol red is plotted against surfac­
tant concentration, as shoim in Figure 2. All the concentrations of 
DSS studied, ho\jever, showed a highly significant increase in the 
absorption of phenol red in the presence of DSS. This significance 
was determined by the student's t test for independent (\mpaired) data 
93 
20.0 
18.0 -
16.0 . 
g lU.o-
•h 
+:> 
& 
g 12.0 
«n 
o 10.0-
cs 
0.1 
> 
8.0 
- 6.0 J 
U.o • 
2 . 0 -
0.0 KM 
0.00 0.2$ 0.^0 1.00 
Concentration of DSS (Percent) 
l.i^o 
Figure 2. Ihfluonce of DSS on the Gastrointestinal Absolution of 
Phenol Red - Intestinal Loops. 
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(at p < .001). For exanple, at 0.2^% concentration of DSS the percent­
age of absorption increased from a control value of U.U to 17.^ percent. 
Hif^her concentrations of the siirfactant increased the absorption of 
phenol red even more, up to a maximum of 73.^8 percent in the presence 
of 1% DSS. This represents about l6-fold increase in phenol red ab­
sorption compared to control studies. A higher concentration of DSS 
(1.5^) showed a smaller increase in absorption than 1% DSS, but never­
theless much more than the control. 
Surfactants can modify drug absorption by one or more mechanism 
or mechanisms. Briefly, they may act on the biological membrane or on 
the drug. In addition, some s\irfactants may also have some pharmaco­
logical properties specific to their particular chemical structure and 
not related to their surfactant properties in general. Mare than one 
of these mechanisms may be operative at the same time, the magnitude 
of each being dependent on the concentration of the surfactant. Sur­
factants can thus exert a two-phase effect which is a function of 
concentration. Below the critical micelle concentration (CMC), absorp­
tion of dnigs may be enhanced due to better contact of the solution 
with the biologic membrane. There also may be a direct effect of the 
surfactant on the permeability of the biologic membrane. Above the 
CMC, a portion of the drug molecules may become "entrapped" in the 
surfactant micelles and, as such, be unavailable for absorption. The 
net effect (absorption enhancement or retardation) depends to some 
degree on the relative magnitude of interaction between the drug and 
the surfactant. The absorption retarding effect usually predominates 
at higher concentrations, because a larger fraction of the drug is 
bound in the micelles. 
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The enhancement of phenol red absorption from its solutions by 
DSS could be the result of ti-ro possible mechanisms. First, a change in 
the physiochemical properties of the drug due to the presence of the 
sxirfactant that could lead to enhanced absorption, and second, an 
alteration in the permeability of the membrane could also lead to 
increased absorption. 
A significant change in the ability of the drug to permeate the 
intestinal membrane may result from an interaction of phenol red with 
DSS to form a conplex. Such a complex coTild have an increased affinity 
for the intestinal lipoidal membrane and result in enhanced drug ab­
sorption. The magnitude of interaction of phenol red with DSS was 
determined by solubility studies (Table 26 and Figure 7). The results 
obtained show that above the CMC of DSS [0.11^] (179), the solubility 
of phenol red increases, indicating micellar complexation. The possi­
bility that such a complex has a higher partition coefficient and, 
hence, results in enhanced absorption seems unlikely on the basis of 
our studies of the effect of DSS on the partition coefficient of phenol 
red and shown in Table 2^, Both premicellar and postmicellar concen­
trations had no significant effect on the partition coefficients. 
However, one must keep in mind that these in vitro studies do not 
necessarily represent what is happening at the biological membrane 
in vivo. 
On the basis of our results (intestinal loop and soltibility 
studies) it can be said tha,t the overall effect of DSS on the phenol 
red absorption may represent the sum of two effects; modification of 
the perineability of the membrane, and micellar complexation of the 
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drug. The results obtained from the influence of the concentration of 
DSS on the phenol red absorption (Tables 1 to U) suggest that the 
former effect (i.e., permeability change allowing for increased absorp­
tion) predominates up to a concentration of 1^ DSS. Above this concen­
tration the micellar entrapment of the drug molecules starts to pre­
dominate and cause a decrease in the absorption of the phenol red. 
Several authors have found that other surfactants also show a similar 
concentration dependent activity (72, 69, 91, 133). 
The effect of various DSS concentrations on the absorption of 
phenol red could be summarized in the following scheme, similar to the 
one proposed by Levy (89). 
Phenol Red-DSS >H.celles DSS Micelles 
Phenol Redx ^DSS 
"""^Non-micellar Complex 
Absorption 
i 
Permeability Enhancing 
Effect on the Membrane 
[More rapid absorption?] 
Our results seem to indicate that DSS, an anionic sxirfactant, 
is preferentially absorbed at the membranes and has conceiv^ly a 
direct effect by disri^sting the highly ordered structure of the gastro­
intestinal epithelium, thus changing its permeability and causing an 
increase in the absorption of phenol red. Nissim (118) and Nadai (113) 
have reported that similar ionic surfactants (sodium lauryl sulfate, in 
particular) caused a disrT:5)tion of the gastrointestinal epithelium and 
thus promoted drug absorption through them. 
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Recently Dujone and Shoemaker (29) have found that combination 
of D3S and oxyphenistan produced cytotoxicity in the liver cell cul­
tures due to increased t:5)take of oxyphenistan by the cells. They have 
also found in the same study that DSS, contrary to the previous belief, 
is itself absorbed from the gastrointestinal tract of the humans and 
the rats. 
Based on our findings and those of others, it is our conclusion 
that DSS changes the permeability of the gastrointestinal epithelim 
and results in its o-wn absorption as well as in increasing the absorp­
tion of other drugs, such as phenol red. 
Absorption of Phenol Red 
in the Intact Rat 
Although the in situ intestinal loop is a useful technique for 
routine exploratory investigation of adjuvants, like surfactants on 
drug absorption, it has some deficiencies, e.g., the animal has been 
surgically manipulated and, therefore, is not under normal physiologi­
cal conditions. The importance of many factors that may influence drug 
absorption, such as gastric en^tying, intestinal motility and the 
direct effect of drugs on the gastrointestinal tract, can be assessed 
only by means of in vivo studies, in the intact animals. Hence, it 
was of interest to consider the ^sorption of phenol red, and the 
effect of the surfactants on its absorption, in the intact rat. F\ir-
thermore, it was also of interest to determine the correlation between 
absorption from in situ intestinal loop technique and absorption under 
normal physiological conditions in the intact rat. 
Tables 6-9 show vudnaiy recovery of phenol red expressed as 
percent of dose after oral administration of 2 ml of 0.7^ mg/ml solution 
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in the presence of various concentrations of DSS. The ratio of the 
amount of phenol red excreted with and -without DSS is plotted against 
increasing concentrations of DSS as a histogram in Figure 3. 
The percent of phenol red absorbed in control animals was, on 
the average, about 5 percent of the dose administered. This value is 
in good agreement with the Intestinal loop experiment and the value of 
3.6 percent reported by Feldman and Gibaldi (UO). The results show 
that for all surfactant concentrations eiiployed there was a significant 
(p < .001) increase in the gastrointestinal absorption of phenol red as 
manifested by increased urinary excretion of phenol red in 2U hours. 
For example, the coadministration of 0.^^ DSS (10 mg) and phenol red 
Increased urinary excretion from about 5.3 percent to 8,U percent, 
about a twofold increase. Higher concentrations of DSS increased the 
urinary excretion even more. Again, a maxim\jm effect was seen to be 
at 1 percent to 1.5 percent (20-30 mg) level of DSS. Higher concen­
trations started to cause a lesser increase in the urinary excretion. 
It is significant to note that the amount of DSS given to 
intact rats varied from 10 to UO mg per rat ; or, on the average, 
approximately $0 to 200 mg per kg body weight of rat. Maximum effect 
was observed at a dose of about 100 mg/kg of DSS (l^ concentration). 
This 100 mg per kg dose of DSS was found to be the ED^q for the fecal 
hydrating effect of DSS in the rats (95). 
Although there were quantitative differences, in the extent of 
absorption, between the intestinal loop and intact rat experiments, 
nevertheless, the concentration dependent activity of the surfactant 
(DSS) in the intact rat followed more or less the same pattein as 
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observed in the intestinal loop. These quantitative differences are 
to be expected in view of the differences in the effective drug and 
surfactant concentrations at the absorption site and due to differences 
in the techniques. 
The results of the intestinal loop and intact rat studies both 
seem to indicate that DSS promotes the dDsorption of phenol red, 
through a mechanism that involves a direct action of the surfactant on 
the membrane permeability. However, in the intact rat, being a more 
complex system physiologically, other possible additional mechanisms 
could also play a role in promoting absorption. For example, DSS has 
been found to inhibit the rate of propulsion of a dye meal through the 
gastrointestinal tract of the rat, chiefly by slowing the gastric 
emptying rate (9U). Such a deify in the gastrointestinal transit rate 
also could be an added factor in promoting the absorption of the drug. 
Absorption of Phenol Red from 
the Peritoneal Membrane 
In view of our findings that DSS changes the permeability of 
the gastrointestinal epithelial membrane and thus causes an increase 
in the absorption of a poorly absorbstble drug, phenol red, it was of 
interest to determine whether DSS will have a similar effect on differ­
ent membrane (peritoneal membrane). 
The results of the influence of DSS on the absorption of phenol 
red from the peritoneal cavity are sho'vm in Tables 10-1^ and Figure U. 
The percentage of phenol red absorbed from the peritoneal cavity in the 
control studies was on the average about percent of the amount of 
the dose administered. This is approximately tenfold the absorption 
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from the gastrointestinal tract. It is knoxm that peritoneal membrane 
is more permeable to drugs than gastrointestinal epitheli\im and our 
results are in accord "vriLth this fact and are in close agreement with 
the findings of Feldman et al. (UO), that phenol red was absorbed 
about tenfold more from the peritoneal cavity compared to the absorp­
tion from the gastrointestinal tract of the rat. The concomitant 
administration of DSS and phenol red resulted in a significant (p <• .01) 
increase in the absorption of phenol red up to 0.1% DSS. Above this 
concentration of DSS the absorption of phenol red started to decrease. 
The concentration dependent activity of the surfactant quali­
tatively follows the same pattern as found in dDsoiption of phenol red 
from both the intestinal loop and the intact rat studies. The extent 
in the increase of absorption was, however, less in the case of peri­
toneal absorption, and this was to be expected because of the differ­
ences in nat\are of the two membranes. 
The results are in accord with the following mechanism: first, 
below the CMC, the surfactant (DSS) potentiated the dDsorption of 
phenol red through direct action on the biological membranes, and 
second, above the CMC the drug is entrapped in the micelle and is not 
readily available for absorption, hence causes a decrease in absorption 
of the phenol red. 
This mechanism is basically similar to the one for the effect 
of DSS on the absorption of phenol red from the intestinal loops and 
in intact rats. However, in the case of peritoneal absorption study, 
smaller amount of the surfactant resulted in an increase in the absorp­
tion of phenol red. These differences stem from the fact that, in 
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case of gastrointestinal absorption, the surfactant can interact with 
mucus and/or other conqaonents of the intestinal fluids, thus reducing 
the effective concentration at the absorption site. 
Influence of Polaxalene on the Absolution of Phenol Red 
Intestinal Loops 
The results obtained from the intestinal loops are shown in 
Tables 16-20. The effect of concentration of the surfactant on the 
relative rate of absorption of phenol red is plotted as a histogram in 
Figure 5. 
Unlike DSS, polaxalene did not cause any significant increase 
in the absorption of phenol red. However, at higher concentrations the 
surfactant caused a significant decrease in dssorption. According to 
our results it seems that polaxalene does not change the permeability 
of the intestinal membrane and, hence, there was no increase in absorp­
tion. These findings are in agreement with the findings of Lish and 
Weikel (96), that 1% polaxalene did not change the ^sorption of phenol 
red from rat colon. It is also in agreement with the lower toxicity 
of non-ionic surfactants compared to ionic surfactants (118). Other 
authors (91j 128, 182) have also sho-wn that other non-ionic s\irfactants 
do not promote absorption of drug solutions from gastrointestinal tract. 
Levy et al. (90) found that polysorbate 80 (a non-ionic surfactant) 
had no apparent effect on the absorption of salicylate, salicylamide, 
and U-aminoantipyrine from their solutions from in situ rat small 
intestine. 
Retardation of phenol red absorption at the higher polaxalene 
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concentrations is due to interaction between the sxrrfactant and drug, 
or, in other words, due to entrapment of the drug in the micelles. 
TdDle 27 and Figure 8 show that phenol red is solubilized by the mi­
celles of the surfactant. Since the drug in the micellar phase is 
unavailable for absorption, the effective concentration of drug is 
less than the apparent concentration of drug; therefore, a decrease in 
absorption is observed. Many authors (72, 89, 91, 133) have found that 
higher concentrations of non-ionic surfactants do decrease drug absorp­
tion. 
Gastric Intubation 
The influence of polaxalene on the absorption of phenol red 
from the intact rat is shorn in Tables 21-2U. The concentration de­
pendent activity of the surfactant is sho^^m in Figure 6. The ratio of 
the amount of phenol red excreted in the urine with and without pol­
axalene is plotted against increasing amounts of polaxalene. 
The results are similar to those obtained in the study of 
intestinal loops where no increase in absorption was noticed at lower 
concentrations of the surfactant, while at higher concentrations there 
was a decrease in absorption. The decrease in absorption of phenol 
red at higher concentrations is due to the entrapment of the drug in 
the micelles of the s\irfactant. 
Influence of DSS on Sulfisoxazole Absorption 
Sulfisoxazole (U.S.P.) is a weak acid, with a pKa of U.62 and 
is a poorly soluble dnig. It is used in human beings for urinary tract 
infections. It is available both as tablets and suspensions. Although 
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sulfisoxazole is well absorbed from solutions, its absorption from the 
solid dosage forms is dissolution rate limited and the U.S.P. now re­
quires a test of dissolution for the tablets as an indication for its 
biologic availability. It was of interest to find out if DSS has any 
effect on its gastrointestinal absorption and the information obtained 
could be valuable for the proper formulation of both tablets and stis-
pensions of this drug. 
Results of absorption studies for the intact rat are presented 
in Tdales 28-30. In control rats about 70 percent of the dose admin­
istered is absorbed in 2h hours. The concomitant administration of 
various concentrations of DSS in the same suspension of the drug sig­
nificantly increased absorption. 
VThen a drug is administered orally in solid form, the rate of 
absorption is controlled by the slowest step in the following sequence: 
dissolution absorption 
Solid drug ^ Drug in Solution > Absorbed drug 
In many instances the slowest or rate limiting step is found to be the 
dissolution of the drug at the atosoiption site. Since dissolution 
step is the rate limiting step, therefore any factor influencing the 
dissolution rate will influence its absorption. The mechanisms by 
which surfactants increase the dissolution rate of a relatively water-
insoluble drug are by decreasing the interfacial tension between the 
dnig and the dissolution medixam and/or by means of micellar solubiliza­
tion . 
To obtain an indication of the ability of DSS to solubilize 
sulfisoxazole, the solubility study was performed and the results are 
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shovn in Table 31 and Figure 9. It was found that the premicellar 
concentrations of dss slightly increased the solubility (about 8%) of 
sxilf i sox azole. 
The fact thsit the solubility of sulfisoxazole was only in­
creased about 8 percent, while its absorption from the gastrointestinal 
tract increased by about 30 percent in the presence of DSS leads us to 
believe that the enhancement of absorption is due to the sum of the 
following two effects; (a) the surfactants increase the effective sur­
face area of the drug through a wetting effect and result in enhance­
ment of dissolution and absorption, and (b) a direct effect on the 
permeability of the membranes resulting in an increased absorption of 
the drug. Other authors (8, h3, ^2, 97, 127, l66) have also found 
surfactants to increase the absorption of poorly soluble drugs by the 
same mechanisms. 
Biopharmaceutical Ingjlications of the Study 
DSS was found to increase the absorption of phenol red, a 
poorly absorbable drug. Our results indicate that the presence of DSS 
with another poorly absorbable drug, oxyphenistan, could have been the 
reason for the latter's hepatotoxicity. The combination of DSS in the 
same dosage form with other drugs not intended for absorption should 
be carefully reconsidered. 
Unlike DSS, polaxalene, which is another medicinally used sur­
factant, did not increase drug absorption. Therefore, when a fecal-
softener is formulated with other laxatives, not intended for absorption, 
polaxalene represents a better choice than DSS. 
CHAPTER VI 
SUMI^A-HT 
A poorly absorbable drug, phenol red, and a poorly water-
soluble drug, sxilfisoxazole, were selected to study the effects of the 
two medicinally used surfactants, dioctyl sodium s\ilfosuccinate and 
polaxalene, on the absoi^ition of former drugs. 
Two techniques, the in situ intestinal loop and gastric intuba­
tion of intact rat, were utilised to study this effect. The solubility 
method of analysis was employed to detect micellar complexation. The . 
partition coefficients (Octanol-l/water) of phenol red in the absence 
and presence of various concentrations of DSS were determined. The 
effect of DSS on peritoneal absorption of phenol red was also studied. 
DSS was found to increase the gastrointestinal absorption of 
both phenol red and sulfisoxazole. It also increased the peritoneal 
absorption of phenol red in the rat. Its effect was concentration 
dependent. The enhancement of drug absorption by this surfactant, DSS, 
is postxilated to be due to a direct effect of surfactant on the biolog­
ical membranes. The decrease in absorption at higher concentrations 
is postulated to be due to micellar entrapment of the drug by the DSS 
micelles. 
Polaxalene was foTond not to increase the gastrointestinal ab­
sorption of phenol red. But its higher concentrations decreased the 
absorption of phenol red due to micellar entrapment. 
Biopharmaceutical iiq)lications of the study were discussed. 
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